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 INFLAMMATION AND STEM CELL TRANSPLANTATION 
Kenneth L. Urish, PhD 
University of Pittsburgh, 2006
 
 
Myoblast transplantation has been investigated as a treatment for Duchenne Muscular 
Dystrophy and injured myocardial tissue. Multiple groups have isolated an early myogenic 
precursor population, termed muscle-derived stem cells (MDSCs) that have a superior ability to 
regenerate dystrophin-positive myofibers and improve cardiac function following an ischemic 
event as compared to more differentiated myoblasts. The initial local environment of these 
transplantations involves a high degree of inflammation and its associated major component, 
oxidative stress. Here, we report that a resistance to these stresses is an important factor 
determining the regenerative capacity of muscle stem cells in skeletal and cardiac muscle. 
MDSCs have an increased antioxidant capacity that protects them from intracellular oxidative 
damage while myoblasts have lower levels of survival and delayed differentiation following 
exposure to oxidative stress. These experiments were conducted using a series of high 
throughput assays that combine robotic live-cell microscopy with custom image analysis 
software. Further, when antioxidant levels in MDSCs are lowered to values comparable to 
myoblasts, the regenerative capacity of MDSCs decreases to levels comparable to myoblasts in 
both skeletal muscle and cardiac cell therapies. These findings indicate the important role 
inflammation plays in cell therapies, and identifies an important new mechanism by which stem 
cells display a unique regenerative capacity and also a new phenotype in selecting cell 
populations with enhanced regeneration capacity.  
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oxidative stress in cell therapies. Each would have been impossible without the advice and 
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Przybycien, and George Stetten. I appreciate their time, expertise, and guidance.  
Designing image analysis software to improve the quantification of images began as an 
idea, but would not be a reality without George Stetten’s graduate class “Methods in Image 
Analysis”.  After one of the classes, a guest lecturer, Jonas August, spent three hours discussing 
an array of approaches to solve a particular technical problem. This conversation marked the 
beginning of a productive collaboration. Aaron Cois, the teaching assistant in the class, became a 
source of infinite knowledge on the many technical details of programming that saved me hours 
of debugging. Finally, the image analysis software would not have been written without the ITK 
toolkit and the dedicated community that has built it. Open source is open science.      
The role of inflammation and oxidative stress in the regenerative capacity of muscle stem 
cells began from a series of scientific posters outside the laboratory of Jon Piganelli. He provided 
outstanding suggestions and advice that allowed the idea to mature and develop. While writing 
my NRSA proposal, the discussions with him and his associate, Clayton Matthews, were the 
source of shaping the application into a successful proposal. His patience and expertise has been 
invaluable.  
The capstone of this work has been in the field of cardiac cell therapy. My success is built 
on the tireless effort and toil of the Cardiac Group in the Stem Cell Research Center: Sensei 
Masaho Okada, Sensei Thomas Payne, and Sensei Hideki Oshima. It has been a pleasure to work 
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with all of you. Arigatou. Further, I would like to gratefully acknowledge Kimimasa Tobita and 
Bradley Keller for their assistance with the cardiac functional analysis. 
My training in the University of Pittsburgh Medical Scientist Training Program has been 
watched closely by my career advisor, Todd Przybycien. We only meet once a semester, but I 
always look forward to the long hike over to Carnegie Mellon to ground my thoughts.  Further, I 
have had the fortunate opportunity to have my desk in the laboratory of Bruno Péault. He is an 
excellent scientist, and I have learned a great deal observing his creativity and scientific thought 
process.  
Special thanks are owed to each member of the Stem Cell Research Center. The graduate 
students that have been my comrades in the lab, especially during the late nights, include: Greg 
Cooper, Karin Corsi, Mitra Lavasani, Wei Shen, and Jenny Zhou. A number of former graduate 
students that have blazed the trail: Dr. Tom Payne, Dr. Ron Jankowski, and especially to Dr. 
Bridget Deasy for always keeping her office door open. The final summer has been an intense 
experience, and the future MD/PhD Joe Vella finished a series of experiments and an inordinate 
amount of cell counting that allowed me to graduate. The laboratory has been fortunate to have 
an excellent technical staff (M. Branca, A. Lu, M. Huard, and J Tebbets) and administrative 
support staff (R. Sauder, J. Hollifman, and J. Cummins). Our laboratory manager, Burhan 
Gharaibeh was a source of a number of useful pieces of advice on my professional development 
and choice of laboratory footwear.  To each and every visiting Japanese Fellows that has 
expanded my cultural horizons – Bokuwa tannaru gakusei desu, anatatachi ga bokuno sensei 
desu.  
Two former mentors have built the foundation for my interests in research: Wayne Curtis 
and Bill Sayles. Dr. Curtis, my undergraduate honors thesis advisor, taught me the value of 
engineering in the biological sciences and the important role of loud music and washing dishes in 
the laboratory. His introduction to bioreactor design and mass transport launched the beginning 
of my professional interests. Mr. Sayles, my high school biology teacher, taught me the 
importance of good questions, the evils of pronouns, and the usefulness of intelligent but 
ignorant Martian friends. I still use these lessons on a regular basis. Have you thanked a green 
plant today? I have. 
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NOMENCLATURE 
ANOVA, analysis of variance 
carboxy-H2DCFDA,  5-(and-6)-carboxy-2´,7´-dichlorodihydrofluorescein diacetate 
CI, confidence interval 
CNPase, 2’,3’-cyclic nucleotide 3’-phosphohydrolase  
DAPI, 4, 6’-diamidino-2-phenylindole  
DEM, diethyl maleate 
DMD, Duchenne muscular dystrophy 
DMEM, Dulbecco’s modified Eagle medium 
EDA, end-diastolic area 
EDD, end-diastolic dimensions 
EP, early preplate, a population of myoblasts 
ELISA, enzyme-linked immunosorbant assay 
ESA, end-systolic area 
ESD, end-systolic dimensions 
FAC, fractional area change 
FS, fractional shortening 
GSH, reduced glutathione 
GUI, graphical user interface 
H2O2, hydrogen peroxide 
ITK, the insight toolkit 
LP, late preplate, a population of myogenic cells 
LTP, long term proliferating cell, a population of MDSCs 
LV, left ventricle 
MCB, monochlorobimane,  
MDSC, muscle-derived stem cell 
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NF-κB, nuclear factor kappa-B 
PBS, phosphate-buffered saline 
RI, regeneration index 
ROS, reactive oxygen species 
SOD, superoxide dismutase 
STS, staurosporine 
TNFα, tumor necrosis factor alpha 
VEGF, vascular endothelial growth factor 
vWF, von Willebrand factor 
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1.0  INTRODUCTION 
Duchenne muscular dystrophy (DMD) is a debilitating disease characterized by the absence of 
dystrophin expression in the membrane-associated cytoskeleton of muscle fibers (Arahata et al., 
1988; Bonilla et al., 1988; Hoffman et al., 1987; Miranda et al., 1988; Zubrzycka-Gaarn et al., 
1988). Dystrophin is the essential link between the subsarcolemmal cytoskeleton and the 
extracellular matrix (Ervasti and Campbell, 1991; Ibraghimov-Beskrovnaya et al., 1992; 
Matsumura and Campbell, 1994; Matsumura et al., 1992; Ozawa et al., 1995), and disruption of 
this link results in muscle fiber necrosis and progressive skeletal muscle weakness (Bonilla et al., 
1988; Menke and Jockusch, 1991; Watkins et al., 1988).  Cell transplantation and a number of 
gene therapy modalities have been explored in an attempt to regenerate dystrophin-positive 
myofibers. This review focuses on the use of myoblasts for cell transplantation, including 
limitations of this technique such as poor cellular migration, immune rejection, and the inability 
of donor cells to survive a host’s inflammatory response. Researchers working to surmount these 
initial limitations isolated postnatal muscle-derived stem cells (MDSCs), a population of early 
myogenic progenitor cells that exhibit a superior ability to regenerate dystrophic muscle. Various 
characteristics of these cells, including self renewal, long-term proliferation, multipotent 
differentiation, and immune-privileged behavior, lead to improved outcome after MDSC 
transplantation.  
1.1 MYOBLAST TRANSPLANTATION 
Initial animal studies revealed that injecting normal myoblasts (satellite cells cultured in vitro) 
into the muscle of mdx mice, a dystrophin-deficient animal model of DMD, regenerated 
dystrophin-positive myofibers to a limited degree. These simple results established two 
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important concepts. First, injected myoblasts can regenerate muscle fibers. Second, because 
dystrophin is only produced in multinucleated fibers, rarely in the injected mononuclear cells, 
these results confirmed the de novo synthesis of dystrophin in the normal location within the 
myofiber, the sarcolemma (Huard et al., 1991a; Huard et al., 1991b; Karpati et al., 1989; 
Partridge et al., 1989). 
These initial promising results in mdx mice motivated researchers to launch a series of 
small-scale clinical trials testing the feasibility of myoblast transplantation (Gussoni et al., 1997; 
Gussoni et al., 1992; Huard et al., 1991a; Huard et al., 1992a; Law et al., 1990; Mendell et al., 
1995; Tremblay et al., 1993). These studies revealed both short- and long-term dystrophin 
expression in the injected muscle, but the number of dystrophin-positive myofibers decreased 
after reaching a maximum one month after injection. These findings corresponded with initial 
observations of an apparent increase in muscle strength followed by a decrease back to baseline 
measurements. 
 
1.2 INITIAL LIMITATIONS OF TRANSPLANTATION 
Further investigations using the mdx mouse model revealed a number of obstacles inherent in 
myoblast transplantation. An observed specific immune response and nonspecific inflammatory 
response resulted in the survival of only a small fraction of the transplanted cells. Both of these 
problems are directly related to the initial oxidative stress induced inflammation and primary 
non-function. Complicating this problem was the limited migration of the injected myoblasts, 
which resulted in only a small, limited area of myofiber regeneration. These problems are 
outlined in Figure 1.   
After cell transplantation, regenerating myofibers were visible only in areas in close 
proximity to the delivered cells, revealing limited migration of the myoblasts (Fan et al., 1996; 
Huard et al., 1994b; Morgan et al., 1993; Satoh et al., 1993). Muscle fibers are multinucleated; 
hundreds of nuclei extend along a single myofiber. After a donor myoblast fuses with a muscle 
fiber, dystrophin restoration does not extend beyond 310 μm of the nucleus, and in many cases 
the regeneration is unidirectional (Gussoni et al., 1997). Despite the poor migration of myoblasts 
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in mdx muscle, donor cell migration is even worse in normal, healthy muscle fibers (Smythe et 
al., 2000). Although some studies have shown that myoblasts can actively migrate to areas of 
injury in response to chemoattractants released from local macrophages (Bischoff, 1997; 
Grounds, 1996), transplanted myoblasts are unable to regenerate dystrophin-positive myofibers 
in areas other than those immediately surrounding the injection site. This limitation continues to 
impede the use of cellular therapy to treat DMD. However, inducing the expression of matrix 
metalloproteinases (MMPs) in myoblasts or injecting MMPs along with myoblasts significantly 
increases migration from the injection site (Caron et al., 1999; El Fahime et al., 2000; Ito et al., 
1998; Torrente et al., 2000).  
The most unsurprising obstacle encountered in myoblast transplantation is immune 
rejection of the transplanted cells. Compared to cell transplantation in immunodeficient mice, 
cell transplantation in major histocompatibility complex (MHC)-incompatible and tolerant host 
mice was less successful (Partridge et al., 1989). The use of immunohistocompatible donors and 
recipients for the first clinical trials still resulted in production of host antibodies in response to 
either donor myoblasts or myotubes (Huard et al., 1991a; Huard et al., 1992a; Torrente et al., 
2001; Tremblay et al., 1993). Muscle biopsies revealed that lymphocytes surrounded the donor 
myoblasts (Gussoni et al., 1997). The immune response elicited by myoblast transplantation is 
intense. When used in an effort to improve the outcome of myoblast transplantation in mice and 
primates, the immunosuppressive agent cyclosporine A (Labrecque et al., 1992; Law et al., 1988) 
is less effective than Tacrolimus (FK506), a stronger immunosuppressive agent (Kinoshita et al., 
1994; Lochmuller et al., 1996).  
Subsequent work led to the characterization of two mechanisms that limit graft 
acceptance: a long-term specific immune response and an acute non-specific inflammatory 
response. These two processes may not be exclusive as early inflammatory events may trigger 
the immune system and limit graft acceptance. Transplanted donor myoblast are rejected even 
after delivery into immunohistocompatible mice. That finding suggests that dystrophin or an 
associated muscle protein acted as an antigen in the dystrophic mice. Although antibodies to 
dystrophin were identified in the host mice (Huard et al., 1992b; Ohtsuka et al., 1998; Tremblay 
et al., 1993), this particular immune response was not responsible for the long-term muscle fiber 
rejection (Bittner et al., 1994; Ferrer et al., 2000; Vilquin et al., 1995). Minor histocompatible 
antigens can induce graft rejection after allotransplantations in both humans and mice, and 
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researchers have posited that these minor antigenic differences may be responsible for the 
immune reaction observed after myoblast transplantation (Boulanger et al., 1997; Guerette et al., 
1995; Huard et al., 1991a; Vilquin et al., 1995). 
Initial studies of myoblast transplantation also identified an even more critical obstacle: A 
large majority of the injected cells were lost to a rapid inflammatory response that occurred 
immediately after injection (Beauchamp et al., 1994; Fan et al., 1996; Huard et al., 1994a). Later 
work revealed that less than 1% of the total number of injected cells remained within the 
recipient one month after transplantation (Beauchamp et al., 1999; Gussoni et al., 1992; Karpati 
et al., 1993; Mendell et al., 1995); Gussoni et al. (1997) reported that 3% to 14% of donor cells 
survived injection. A targeted immune rejection could not be responsible for this widespread cell 
death within such a short time span. Further, the cell death occurred even in the absence of a 
humoral immune response. The short-term reduction in the donor myoblast population was 
similar in immunodeficient, immunocompromised, and immunohistocompatible donors (Gussoni 
et al., 1997; Huard et al., 1994a). These factors suggest a more acute inflammatory response. 
Indeed, additional studies revealed infiltrating polymorphonuclear cells, macrophages, natural 
killer cells, and neutrophils surrounding the injected donor myoblasts. In addition, inhibiting the 
non-specific inflammatory response by using monoclonal antibodies that blocked leukocyte 
adhesion or by genetically engineering injected myoblasts to express anti-inflammatory 
interleukins improved initial myoblast survival (Guerette et al., 1997a; Qu et al., 1998). These 
results support the hypothesis of the non-specific inflammatory response; however, these gains 
cannot entirely account for the rapid cell loss that occurs after transplantation, which suggests 
that other events play an important but undefined role.       
Perhaps the critical short-term factor responsible for successful myoblast transplantation 
does not hinge upon the immune response of the host but, rather, on the potential of the donor 
myoblasts. Normalization of the number of injected cells to exclude the cells eliminated during 
the first 24 hours after injection suggests that a small number of cells is responsible for the 
regeneration of a very large number of dystrophin-positive myofibers. Compared with the 
number of viable nuclei remaining after the enormous cell loss, the total number of donor nuclei 
within the resultant muscle grafts is dramatically higher (Beauchamp et al., 1999; Qu et al., 
1998). Analysis of long-term myoblast transplantation grafts in human clinical trials showed that 
half of the donor myoblast nuclei had fused to host myofibers, and some of the donor myoblast 
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nuclei were found outside the sarcolemma closely associated with a single myofiber, similar to 
the location of satellite cells (Gussoni et al., 1997). These final two points suggest that the cells 
that survived after injection had a remarkable propensity for proliferation and differentiation.  
Muscle development does not follow the simplistic model of a homogenous group of 
satellite cells fusing with myotubes to repair muscle fibers (Goldring et al., 2002; Seale and 
Rudnicki, 2000; Zammit and Beauchamp, 2001). Instead of transplanting a population of cells 
that would survive the initial inflammatory response and proliferate, researchers performing 
early studies of myoblast transplantation used a heterogenous population of efficient and 
inefficient cells, which decreased the potential for skeletal muscle regeneration. Was it possible 
to isolate this distinct population of muscle cells? 
 
Figure 1: Obstacles in Myoblast Transplantation.  
The three primary obstacles initially encountered in myoblast transplantation used 
to treat DMD patients 
1.3 IMPROVED SKELETAL MUSCLE REGENERATION 
Until recently, it was difficult to obtain pure skeletal myogenic cultures because primary cultures 
of disassociated muscle tissue contain an array of cell types. including neurovascular and 
connective tissue (Dai et al., 1992; Morgan et al., 1990; Partridge et al., 1989; Watt et al., 1982; 
Watt et al., 1984). Rando and Blau (Rando and Blau, 1994) developed a preplate technique that 
allows researchers to preferentially select myogenic cells and eliminate other non-myogenic 
tissue from the culture on the basis of the cell types’ differing propensities to adhere to collagen-
coated tissue culture flasks. Figure 2 illustrates the preplate technique (Richler and Yaffe, 1970).   
 5 
If only a small minority of cells survived transplantation, researchers in our laboratory 
hypothesized that these cells were a special subpopulation of muscle cells (Qu et al., 1998). 
Furthermore, if the preplate technique could be used to separate myoblasts from non-myogenic 
cells, it also could enable the isolation of different populations of myogenic cells. Both of these 
hypotheses turned out to be correct. 
The preplate technique can be used to isolate three distinct populations of myogenic cells 
discernable on the basis of their ability to regenerate dystrophic muscle. The population of cells 
isolated from the early preplate (EP) expressed myogenic markers, proliferation behavior, and 
regenerative capacity comparable to satellite cells.  When cultured in vitro, EP cells divide a 
limited number of times before fusing and have a limited ability to regenerate dystrophin 
expressing myofibers in vivo (Qu-Petersen et al., 2002). The expression of an array of myogenic 
regulatory factors suggests that EP cells are strongly committed to the myogenic lineage 
(Jankowski et al., 2002a). The second population of skeletal muscle–derived cells, isolated from 
the sixth or subsequent preplates, was termed the late preplate (LP) cell population. These 
myogenic cells differ from the EP cells by exhibiting slower division and a lack of fusion with 
other myoblasts. LP cells can only be cultured for a limited time before they differentiate toward 
myofibers. However, after two weeks, clonal populations of a previously unidentified population 
appear from quiescent LP cells. This third myogenic cell population, termed long-term 
proliferating (LTP) cells, exhibits a superior ability to regenerate dystrophin-positive muscle 
fibers within mdx skeletal muscle when compared with satellite cells (Huard et al., 2003).    
These LTP cells appeared to be an early progenitor population of myogenic cells on the 
basis of the cells’ scarcity in muscle tissue and absence of the expression of myogenic genes, the 
most classic of these being MyoD. More importantly, muscle-derived cells from preplate 6 (PP 
6) appeared to be the unique population of myoblasts that avoided rapid cell death after 
transplantation. When transplanted into skeletal muscle, cells from preplate 1 underwent rapid 
cell death, whereas most cells from preplate 6 survived after transplantation. Indeed, the PP 6 
cells appeared to proliferate after injection (Qu et al., 1998; Qu and Huard, 2000) These 
experiments were completed in MHC-matched mice.  
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 Figure 2: The preplate technique.  
Dissociated skeletal muscle–derived cells harvested from a C57BL-6J and 10J mice are 
separated on the basis of their adhesion to collagen-coated flasks over a 4- to 7- day period. This 
technique leads to the isolation of three populations of cells distinguishable by their varied 
abilities to regenerate dystrophic muscle (Qu-Petersen et al., 2002). More than four different 
populations have been isolated by using the preplate technique followed by FACS for CD34, 
Sca-1, and c-kit (Jankowski et al., 2001). 
1.4 MECHANISM OF IMPROVED MUSCLE REGENERATION 
What was the mechanism behind the LTP cell population’s increased ability to regenerate 
skeletal muscle? These early myogenic progenitor cells had a distinct phenotype that included 
relatively high levels of proliferation and a propensity for continued self-renewal. Furthermore, 
this cell population acted as a single unit capable of regenerating all the different cell types 
necessary for functional muscle. On the basis of their unique self-renewal properties and capacity 
to undergo multilineage differentiation, these LTP cells came to be called muscle-derived stem 
cells (MDSCs) (Deasy et al., 2003; Huard et al., 2003; Jankowski et al., 2002b).   
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Compared with satellite cells, MDSCs exhibit higher rates of proliferation and lower 
levels of fusion, which together lead to increased myofiber regeneration. After a progenitor cell 
fuses with a myotube, it loses the ability to proliferate and increase the number of dystrophin-
positive myofibers in the dystrophic muscle. The bulk of satellite cells undergo a limited number 
of divisions before fusion (Jankowski et al., 2002a). These phenotypic characteristics are 
important across multiple animal models. Cell proliferation and differentiation correlate with 
skeletal muscle regeneration in vivo not only in mice after injection of mouse myogenic cells but 
also in rats after injection of rat myogenic cells (Jankowski and Huard, 2004). MDSCs have a 
CD34-positive phenotype that is associated with a superior ability to regenerate muscle fibers. 
Compared with CD34-negative LP cells, CD34-positive LP cells have a decreased tendency to 
fuse and exhibit higher levels of proliferation, despite the fact that both populations exhibit a 
similar low degree of myogenic commitment. Interestingly, as the cells begin to fuse they switch 
to a CD34-negative phenotype (Jankowski et al., 2002a).   
The cellular division of MDSCs does not follow traditional exponential growth kinetics, 
which are based on the assumption that a cell population is 100% mitotically active. Similar to 
other stem cell populations, clonal populations of MDSCs exhibit the ability to self-renew. The 
cells follow non-exponential growth with various fractions of cells dividing or existing in 
different states of the cell cycle, including quiescence, at any given time. This asymmetric cell 
division is measurable in vitro (Deasy et al., 2001; Deasy et al., 2002). Mathematical analysis of 
the kinetics has revealed MDSCs to be a heterogeneous population of cells containing 
proportional numbers of cells that are quiescent, mitotically active, or differentiating (Deasy et 
al., 2003). This work was important because it established that MDSCs actively produce two 
populations of cells: a quiescent population for future muscle repair and a population of cells for 
immediate muscle repair. This behavior is similar to that of heterogeneous populations of muscle 
progenitor cells, which maintain distinct populations of quiescent and rapidly proliferating cells 
(Goldring et al., 2002; Zammit and Beauchamp, 2001).  
Whereas their asymmetric division suggests MDSCs’ capacity for self-renewal, in vivo 
studies have definitively demonstrated it. After MDSCs reconstituted the bone marrow of an 
irradiated mouse, bone marrow from that animal was able to rescue a second mouse; these results 
are indicative of a long-term repopulation capacity of MDSCs (Cao et al., 2003; Jackson et al., 
1999). In addition, results demonstrating the multilineage potential of MDSCs (Lee et al., 2000; 
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Qu-Petersen et al., 2002) were generated from a single clonal cell. These experiments 
demonstrate that MDSCs possess the capacity for self-renewal after differentiation toward any of 
various tissue lineages. Such self-renewal is critical during muscle regeneration because it does 
not place a finite limit on the number of divisions that cells must undergo before differentiating 
toward myotubes. 
The antigenic properties of a cell population also play a crucial role in the success of their 
engraftment. An initial clonal population of MDSCs induced a T-cell–mediated immune 
response similar to those observed in initial myoblast transplantation experiments. (Kimura et al., 
2000; Qu et al., 1998). Another subclonal population, LTP cells, failed to elicit an immune 
response in immunocompetent mice and generated dystrophin-positive muscle fibers in grafts 
that persisted for more than 2 months (Fig. 3). These results support the findings of Qu-Petersen 
et al. (2002). Compared with myoblasts, LTP cells exhibit a superior ability to regenerate 
dystrophic skeletal muscle because injected LTP cells and the resultant dystrophin-positive 
myofibers are not destroyed by immune rejection. Interestingly, MDSCs have naturally low 
levels of MHC-I expression, a possible artifact of several passages in vitro (Qu-Petersen et al., 
2002). Although MHC levels may hinder a T-cell–mediated immune response, a lack of MHC 
expression can activate an attack by natural killer (NK) cells (Vilches and Parham, 2002). Neural 
stem cells also exhibit low MHC expression and do not stimulate an NK or T-cell response. 
However, upregulating MHC expression on the neural stem cells by exposing them to interferon-
gamma activates both NK and T-cells (Mammolenti et al., 2004). MHC-I expression can also be 
controlled by the intracellular redox balance. Inflammation can enhance and activate MHC-I 
expression on the cellular membrane. If MDSCs were more resistant to the initial inflammatory 
response, perhaps MHC-I expression was delayed or avoided. A great deal of work remains to 
define a plausible mechanism for the immune-privileged status of MDSCs.     
The ability of MDSCs to regenerate muscle extends beyond the cells’ capacity to 
generate a large number of myotubes that are not susceptible to immune rejection. The MDSCs 
also demonstrate pluripotency by regenerating not only myogenic cells but also the 
neurovascular cells that are necessary to completely regenerate the tissue. For example, an 
MDSC subclone expressed 2’,3’-cyclic nucleotide 3’-phosphohydrolase (CNPase) and von 
Willebrand factor (vWF) markers in vitro, markers that are indicative of neural and endothelial 
cells, respectively. Stimulation of the clones with neuronal growth factor (NGF) and vascular 
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endothelial growth factor (VEGF) increased their expression of CNPase and vWF, respectively. 
In the cultures stimulated with VEGF, as the expression of vWF increased, the levels of desmin, 
an early marker of myogenic differentiation, decreased (Qu-Petersen et al., 2002). Nervous tissue 
and vasculature are essential to the survival of muscle tissue. The physical environment of 
regenerating muscle may induce MDSCs to differentiate into the multiple lineages necessary for 
complete muscle regeneration.  
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 Figure 3: MDSCs have an impressive ability to regenerate persistent dystrophin-positive 
myofibers in immunocompetent mice.  
A total of 2x105 MDSCs were injected into both gastrocnemius muscles of 6-week-old mdx 
mice. The recipient mice were sacrificed at specific time points, and the muscle was 
immunostained for dystrophin. Typical results are shown 2 wks (A), 4 wks (B), and 8 wks after 
injection (C). All images are at 100x magnification. The dystrophin-positive myofibers were 
counted at each time point (n=4), and this number was presented as a function of the 
regeneration index: the number of dystrophin-positive myofibers normalized to 1x105 injected 
cells (D). The regeneration index remained relatively constant between each time point 
(450±163 at 2 wks, 702±218 at 4 wks, and 446±121 at 8 wks). A two-tailed t test revealed no 
statistical difference between the regeneration indices calculated at each time point (2 vs. 4 
wks, P=0.11; 2 vs. 8 wks, P=0.97; 4 vs. 8 wks, P=0.08). These results support the work of Qu-
Petersen et al. (2002).   
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1.5 MDSCS AND THE DEVELOPMENT OF MUSCLE 
Conventional thought in muscle regeneration included a model of quiescent satellite 
cells that were activated by muscle injury, proliferated into myoblasts, and fused to form 
myotubes. The small population of transplanted cells responsible for the majority of muscle 
regeneration and the isolation of adult MDSCs did not agree with this model. Instead, these 
findings added to a growing body of evidence suggesting that multiple, distinct populations of 
satellite cells reside in muscle and play different roles during regeneration (Goldring et al., 2002; 
Seale and Rudnicki, 2000; Zammit and Beauchamp, 2001).  
At a minimum, satellite cells comprise two distinct cell populations: quiescent and highly 
proliferative cells. A picture of the two populations emerged as studies demonstrated the self-
renewal ability of satellite cells (Zammit and Beauchamp, 2001).  The identification of two 
distinct patterns of growth kinetics offered the first evidence that not all satellite cells are 
equivalent (Grounds and McGeachie, 1987; McGeachie and Grounds, 1987; Schultz, 1996). 
Other studies showed a population of satellite cells that normally existed in a quiescent state but 
could form the rapidly proliferating population of cells responsible for regenerating muscle 
(Baroffio et al., 1996; Molnar et al., 1996; Yoshida et al., 1998). These findings suggested that 
the quiescent population of cells is a progenitor of the population of rapidly proliferating satellite 
cells. Additional irradiation experiments supported the existence of this quiescent population. 
Initially, mononucleated cells failed to migrate from myofibers irradiated in vitro. However, at 
later time points, a second population of myogenic cells were observed to migrate off of the 
cultured myofiber suggesting that they were initially a quiescent population. (Gross and Morgan, 
1999; Heslop et al., 2000; Quinlan et al., 1995; Wakeford et al., 1991). Connecting the 
expression of β-galactosidase to the expression of Myf5, the earliest marker of myogenic 
commitment, these two populations could be distinguished from each other by the expression of 
CD34 (Beauchamp et al., 2000).  
Initially, researchers believed MDSCs to be one of these populations of satellite cells 
(Gussoni et al., 1999), but further investigation revealed that MDSCs were a more 
undifferentiated precursor of satellite cells. Satellite cells are defined by a combination of their 
morphologic location next to the muscle fiber and their expression of several cell markers and 
transcription factors outlined in Figure 4, including m-cadherin, desmin, and Pax7 (Zammit and 
Beauchamp, 2001).  MDSCs are distinguishable from satellite cells on the basis of cell marker 
expression patterns; the ability of MDSCs to differentiate into multiple lineages, including blood; 
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and, importantly, the superior ability of MDSCs to regenerate dystrophin-positive myotubes 
(Deasy et al., 2001; Huard et al., 2003; Jankowski et al., 2002b).  
The latter of these genes, Pax7, was initially regarded as a signal of MDSCs’ 
commitment to the myogenic lineage because Pax7 knockout mice completely lack satellite 
cells but contain a normal size population of MDSCs (Seale et al., 2000). Further study revealed 
a more complicated picture. Other groups subsequently reported that Pax7 knockout mice 
actually do possess a satellite cell population as defined by morphologic location and CD34 
expression. However, compared to normal mice, these mice contain a smaller population of 
satellite cells that are unable to completely repair injured muscle (Oustanina et al., 2004). A new 
picture is emerging in which Pax7 helps control satellite cell proliferation and self-renewal 
(Olguin and Olwin, 2004; Oustanina et al., 2004; Zammit et al., 2004). A schematic of a 
 
proposed model for the development of a myofiber appears in Figure 4. 
 
Figure 4: A possible mechanism of myogenic differentiation.  
er differences between MDSCs A possible mechanism of myogenic differentiation. Key cell mark
and satellite cells include an upregulation of myogenic regulatory factors (MRF), including Pax7, 
c-Met, Myf5, and desmin. Cell markers used to distinguish the different stages of myogenic cells 
are based on the following references: (Beauchamp et al., 2000; Cornelison and Wold, 1997; 
Jackson et al., 1999; Lee et al., 2000; Qu-Petersen et al., 2002; Seale and Rudnicki, 2000; Seale 
et al., 2000; Yoshida et al., 1998; Zammit et al., 2004). Discrepancies are noted as ±.  
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1.6 TISSUE ENGINEERING AND MDSCS 
The ability of the MDSCs to differentiate into various lineages in muscle tissue prompted our 
group to explore the ability of these cells to repair osteogenic defects. After being transduced 
with a vector to express bone morphogenetic protein 2 (BMP-2) and injected into the bone of an 
allogenic host, the cells formed bone matrix and differentiated into osteocytes and osteoblasts 
(Bosch et al., 2000; Lee et al., 2000; Musgrave et al., 2000; Shen et al., 2004a). When implanted 
in a critical-size skull defect in mice, these cells healed the bone defect (Lee et al., 2000; Shen et 
al., 2004a) Critical to the definition of a stem cell, when implanted in a large defect in a mouse 
femur, MDSCs underwent osteogenic differentiation and facilitated almost complete functional 
recovery. The repaired femur was similar to a normal uninjured femur in terms of strength and 
biomechanical properties (Shen et al., 2004b).   
Muscle derived stem cells have also been shown to differentiate into hematopoietic 
lineages (Cao et al., 2003; Gussoni et al., 1999; Jackson et al., 1999). By using FACS Hoechst 
33342 exclusion, it is possible to isolate from muscle tissue a population of stem cells, termed 
side population (SP) cells because they were a side population of the collected sample; these 
cells  can regenerate dystrophin-positive myofibers in mdx mice and repopulate the bone marrow 
and rescue lethally irradiated mice (Gussoni et al., 1999). Cao et al. (2003)(Cao et al., 2003) 
demonstrated that MDSCs can differentiate toward hematopoietic lineages while, at least 
partially, preserving their myogenic potential. Bone marrow isolated from a primary mouse 
recipient could rescue a second irradiated mouse and regenerate dystrophin-positive myofibers in 
its muscle. This study demonstrated the ultimate level of plasticity of MDSCs; the cells changed 
their lineage in response to the local environment. These experiments also provide a classic, 
rigorous test of the multilineage differentiation potential of MDSCs by going beyond a simple 
evaluation of cell marker expression and assessing the ability of MDSCs to rescue irradiated 
mice, an assay that demonstrated the ability of MDSCs to differentiate into functional blood 
cells. 
Stem cell–based therapy holds promise as a possible treatment for DMD, but there are 
still several hurdles to overcome before clinical applications become reality. First, after very 
extensive passaging in vitro, clonal populations of MDSCs develop a heterogeneity that limits 
their ability to regenerate muscle. Second, MDSCs are an exceptionally rare type of myogenic 
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cells, which means that a degree of expansion would be necessary to generate the quantities of 
cells required for any clinical therapy. Third, the immune acceptance of injected cells is critical, 
which means that the mechanism behind the unique immune-privileged status of certain 
myogenic populations needs to be better understood. Finally, the delivery method of the cells 
needs to be improved. Stem cells delivered intra-arterially have regenerated muscle and restored 
muscle function in α-sarcoglycan knockout mice (Sampaolesi et al., 2003). The expression of 
adhesion molecules can enhance the efficiency of systemic delivery of MDSCs by increasing 
their homing potential (Torrente et al., 2003). Systemic delivery is potentially advantageous in 
terms of safety, simplicity, and effectiveness and may provide a therapeutic benefit for treatment 
of DMD. Finally, additional study is needed to more fully evaluate the functional improvements 
elicited by myoblast transfer therapy. 
On a technical note, a limitation in the field includes the inability to automate the 
quantification of the levels of regeneration and cell phenotypes in vitro. The first portion of this 
dissertation will focus on developing and improving these technologies. In the final section, 
these technologies will be utilized to investigate the mechanism behind the superior regenerative 
capacity of MDSCs as compared to myoblasts.    
1.7 PROJECT OBJECTIVES 
1.7.1 Objective #1: Development of Automatic Thresholding Algorithm 
MDSCs have shown an enormous potential as a useful cell population in dystrophic skeletal 
muscle therapies. However, quantifying levels of dystrophin-positive myofiber regeneration is 
slow and time consuming. Further, accurate software does not exist primarily because of 
limitations in the development of efficient automatic threshold algorithms. We develop and 
validate an automatic threshold routine that can be useful in these tasks.  
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1.7.2 Objective #2: Robotic, Live-Cell Microscopy High Throughput Assays.    
 
A series of survival and differentiation assays were needed to characterize phenotypic 
differences between myoblasts and MDSCs. Novel image analysis software was designed that 
automated a live cell microscopy technique, and created efficient, accurate, and high throughput 
assays that were critical to completing experiments discussed in objective #3. This is an 
interesting new technical approach to conducting live cell microscopy because analysis is 
conducted in a similar fashion to flow cytometry.   
1.7.3 Objective #3: Mechanism of Increased Regenerative Capacity of Muscle Stem Cells: 
Role of Oxidative and Inflammatory Stress 
MDSCs have a superior ability to regenerate dystrophic skeletal myofibers and improve the 
function of cardiac tissue following ischemic episodes as compared to myoblasts (EP cells). 
Previous work has demonstrated that MDSCs long term capacity for proliferation and 
multipotency may play an important role. However, many groups have observed inflammation at 
the site of myoblast transplantation in both skeletal and cardiac cell transplantation. We 
hypothesized that perhaps an important, unconsidered phenotype in MDSCs’ regenerative 
capacity was a resistance to oxidative stress. We assessed the survival and differentiation 
phenotypic ability of MDSCs and myoblasts to resist oxidative and inflammatory stress. We then 
observed any differences in antioxidant capacity. Finally, we completed an extensive series of 
experiments to decrease levels of MDSCs’ antioxidant capacity to similar levels as myoblasts. 
We assessed any differences in regeneration capacity of the MDSCs and MDSCs with decreased 
antioxidant capacity in the dystrophic skeletal muscle and ischemic cardiac animal models.  
Image analysis technologies served an important role in conducting these experiments. 
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2.0  UNSUPERVISED SEGMENTATION FOR MYOFIBER COUNTING  
2.1 INTRODUCTION 
Immunohistochemistry is a valuable technique that measures protein expression in cell culture 
and tissue sections by labeling a protein, such as dystrophin, with an antibody attached to a 
fluorescent signal. Many research groups are interested in automating the measurement of 
muscle regeneration in therapies for muscular dystrophy. The gold standard for measuring 
muscle regeneration uses immunohistochemistry to stain dystrophin-positive myofibers on a 
longitudinal muscle section so that the number of regenerated myofibers can be counted. Current 
therapies result in a few thousand myofibers being generated in a single muscle (Qu-Petersen et 
al., 2002). Manually counting such a large quantity is tedious and time consuming, but remains 
standard practice due to the lack of an accurate automated processes. Further, this analysis only 
assesses the local expression of dystrophin, but ignores the longitudinal distribution of 
dystrophin expression, i.e. the distribution of dystrophin expression as a function of position 
along the muscle fiber. This is one of the main limitations of current therapies (Urish et al., 
2005). To design experiments that address this problem, we developed an algorithm to 
automatically count the number of dystrophin-positive myofibers on an immunofluorescent 
image, allowing three-dimensional dystrophin expression to be quantified.  
2.2 UNSUPERVISED THRESHOLDING 
Thresholding is often used to segment an image. Ideally, the two populations of pixels to be 
classified (foreground and background) would have distinct ranges of image intensities with 
minimal overlap to form a bimodal histogram (Fig. 5). However, images of myofibers 
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immunostained for dystrophin (Fig. 5B) and immunofluorescent images in general have 
unimodal image histograms (Fig. 5C) where an appropriate threshold is not obvious. We have 
developed an algorithm to automatically select a threshold for immunofluorescent images by 
searching for the threshold which maximizes the number of connected components of the 
thresholded image. 
We have observed that the number of connected components as a function of threshold is 
smooth in the vicinity of the maximum. The search for this optimal threshold is implemented 
using a modified bisection method. Cells typically have a pixel area greater than 100 pixels 
(Retiga 1300 camera at 200x magnification) so that components below 50 pixels, the only input 
parameter, were ignored to eliminate noise. This approach is based on the following logic. If the 
threshold is set too low, the number of connected components is too low because some of the 
myofibers will not be detected (Fig. 6B). Conversely, if the threshold is too high, the number of 
connected components is too low because the white border separating the myofibers is eroded 
away connecting individual myofibers (Fig. 6D). This suggests that a reasonable threshold 
maximizes the number of sub-thresholded connected components (Fig. 6E). If this optimum 
threshold is used, from an anecdotal perspective, the image appears to be correctly segmented 
(Fig. 6C) compared to the original image (Fig. 6A). This algorithm is a variant of a method 
termed topological stable-state thresholding (Pikaz and Averbuch, 1996). 
 
Figure 5: Possible Image Histograms.  
The threshold used to separate two populations is apparent if the image histogram is bimodal 
(A). However, an immunofluorescent image of myotubes immunostained for dystrophin (B) has 
a unimodal image histogram (C), and the appropriate threshold is not clear. Note that (B) is only 
a small portion of the overall image of a regenerated muscle. Here, Ф represents pixel intensity. 
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Figure 6: Outline of Stable State Thresholding Strategy.  
The original image (A) is thresholded at a low (B), medium (C), and high (D) pixel intensity. 
The number of connected components above a user defined minimum area is plotted if the image 
was thresholded at all pixel intensities (E). Images B, C, and D are shown at their respective 
points on the curve in E. This suggests that an optimal threshold point can be identified based on 
maximizing the number of connected components in an image. 
 
2.3 PROPOSED METHOD AND ITK IMPLEMENTATION 
The Insight Toolkit (ITK) is an open source C++ library used to design and implement 
algorithms for image analysis (Yoo et al., 2002), and was used to rapidly assemble and test the 
feasibility of this method. Figure 7 outlines the pseudo-code of the algorithm using a modified 
bisection method. The minimum and maximum pixel intensities of the image are the set as the 
two endpoints. Each segment between an endpoint and the midpoint is bisected for the initial two 
evaluation points. The image is thresholded at each point, and the ITK classes, 
ConnectedComponentsImageFilter and RelabeledComponentsImageFilter, are used to count the 
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number of connected components above the minimum object size on each binary image. The 
point with the higher number of objects is set as the new midpoint, and the point with the lower 
number of objects is set as the new endpoint. The process is repeated until the two endpoints are 
two pixel intensities apart. Any number of other numerical methods for optimization without 
derivatives can be used to search for the maximum including Brent’s and the golden ratio 
method.           
This method of unsupervised segmentation has two inherent advantages. First, the only 
necessary input is the minimal area of the segmented objects; this parameter is known a priori, 
which we can exploit to help eliminate background noise. Second, the method employs a natural 
coarse-to-fine search strategy.  Since the function is sampled at the three most widely separated 
intensities in the initial iteration, the function is, in effect, smoothed at a large scale and thus 
avoid local maximums. The sample selection has the effect of reducing the degree of smoothing 
with each iteration, i.e., decreasing as the search scale as the estimated maximum is approached.  
(We note that subsampling is a well-known strategy for regularizing ill-conditioned inverse 
problems, such as numerical differentiation.)  It is possible that a local maximum near the global 
maximum may be identified; however this is an equally acceptable solution as little difference 
exists between the two answers in terms of number of components, which is the desired 
objective. 
Further, ITK is a valuable tool to implement automated threshold-based segmentation of 
immunofluorescent images. Different numerical methods or other approaches can easily be 
tested to identify the best optimization or search strategy. The generic ITK pipeline allows the 
easy addition of edge enhancement features in situations where thresholding is not an entirely 
sufficient method for segmentation. In addition, standard image processing operations such as 
connected components that are challenging to code and debug are already reliably implemented 
in ITK.          
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Input: Minimum object area
Initial endpoints: (minimum and maximum pixel values)
Bisect each segment between the two endpoints and the midpoint
On each of the 2 points:
Binary threshold filter (itk::BinaryThresholdImageFilter)
Connected components filter (itk::ConnectedComponentsImageFilter)
Relabeled components filter (itk::RelabeledComponentsImageFilter)
Discard objects below minimum object size 
Count the number of connected components 
Set the high bisection point as the new midpoint 
Set the low bisection point as a new endpoint.
Repeat until the search interval is two pixel intensities apart 
 
Figure 7: Outline of Topological Stable State Thresholding Algorithm.  
The proposed method for unsupervised segmentation of immunofluorescent myofiber images 
uses a modified bisection method to search for the threshold point. 
2.4 RESULTS AND DISCUSSION 
To test the ability of this approach to measure three-dimensional regeneration, a series of serial 
cryostat sections of a regenerated muscle was stained, imaged, and measured with our algorithm. 
A longitudinal plot of the number of dystrophin-positive myofibers as a function of the length of 
the muscle, starting at the beginning of the engraftment, demonstrates the three-dimensional 
measurement of tissue regeneration (Fig. 8B). It was interesting to compare this method to other 
previously described and commonly used automatic threshold routines including the Otsu and 
Isodata methods (Otsu, 1979). As shown in Figure 9, both of these algorithms were extremely 
accurate when an image had a low number of objects, but had increasing levels of error as the 
number of objects in an image increased. The reverse was true with the topological stable state 
method. A major obstacle in therapies for muscular dystrophy is the low migration of dystrophin 
gene vectors that result in a limited longitudinal distribution of dystrophin expression (Urish et 
al., 2005). This automated algorithm will facilitate quantifying this measurement, allowing us to 
design experiments that address the limited distribution of dystrophin-positive myofibers. 
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Figure 8: Validation of Topological Stable State Algorithm.  
Validation of this algorithm (n=63) revealed that images that contained more than 100 objects 
varied by less than ±10% (solid lines) from manual counts (A). After validation, this algorithm 
was used to measure the number of dystrophin-positive myofibers on a set of 30 serial cryostat 
cross sections of a single muscle, and a longitudinal plot of the counts displays the 3-D 
distribution of dystrophin expression (B).  
 
 
Figure 9: Comparison of Topological Stable State Thresholding Approach to other 
Methods  
The number of dystrophin-positive myofibers on a series of 75 images was counted using A) the 
new automatic threshold method we have developed, B) the isodata automatic threshold 
method, and C) the Otsu automatic threshold method.  Each point in the three plots is the 
separate image where the software count was compared to a manual count of myofibers. The 
lines are ± 10% disagreement between the software and manual counts.  The arrows in each 
plot point out the regions where the software has more than 10% disagreement with the manual 
counts of the images, the gold standard of measurement. As shown, our method is very 
accurate when there are more than 100 myofibers in an image. This is the same point where the 
other two methods typically used in commercial software become error prone. The images we 
want to count have a large number of dystrophin-positive myofibers. 
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3.0  REAL TIME FLOW CYTOMETRY CONDUCTED USING ROBOTIC LIVE 
CELL MICROSCOPY   
3.1 INTRODUCTION 
Automated high-throughput microscopy has been used to describe cell phenotype including 
motility (Bahnson et al., 2005), proteomics (Perlman et al., 2004; Sigal et al., 2006), and 
genomic data (Neumann et al., 2006). Major technical hurdles in using automated microscopy 
for profiling strategies include image segmentation, analysis, and visualization of the results. 
Here we present imaging software that approaches high through-put microscopy from the 
perspective of flow cytometry. As a proof of concept, we have used the early apoptotic marker, 
annexin-V, to monitor levels of cell death over a continuous time period to validate the software 
and approach.  
Flow cytometry and fluorescent microscopy have become essential techniques in the 
laboratory allowing different aspects of the cell to be observed and measured. In each case, there 
are three approaches to fluorescently label a cell: an antibody specific for a protein conformation 
tagged with a fluorescent molecule, a chemical that covalently binds with a macromolecule or 
becomes trapped in a cell, and fluorescent protein whose expression is linked to a particular 
transcription promoter. The last two types are particularly convenient in live cell microscopy 
because cells can be labeled and classified while they are still viable, and the state of the cell can 
be observed in response to stimuli or changes in environment. Flow cytometry is a valuable 
technique because of its powerful ability to rapidly quantify the light scattering and fluorescent 
properties of a cell, and then sort these populations for isolated, continued analysis in vitro or in 
vivo. Due to the automated nature, flow cytometry is particularly useful in quantifying a cell 
population due to its large sample size and cell specific measurements. However, detaching a cell 
from the culture flask may alter its state. Further, one sample can only be measured at one time 
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point. Fluorescent live-cell microscopy is valuable because it permits the observation of a cell for 
a prolonged time period while the cell is viable, and also possesses the quantitative potential that 
flow cytometry does. 
Here, we propose combining the advantages of both live cell fluorescence microscopy 
and flow cytometry. A robotic stage microscope fitted with an incubator is used to image a series 
of locations on a cover-slip or culture plate at a repetitive time interval. Custom built, open 
source image analysis software is used to quantify the collected results. This allows full 
automated, unbiased observation and measurement of cell fluorescence. Cells are segmented on 
images using a loading dye and fractions of cells positive for a fluorescent signal and the strength 
of the signal are measured. The image analysis software sends output directly to a text file. Data 
is also written to a flow cytometry standard (FCS) file format (Seamer et al., 1997). This permits 
visualization and analysis using flow cytometry analysis software from a variety of vendors. The 
software developed in this study is freely available, and the source code can be downloaded and 
compiled on multiple platforms including, windows, macintosh, and linux operating systems. 
3.2 RESULTS 
3.2.1 Live Cell Microscopy is Similar to Flow Cytometry 
The large number of images collected using robotic time-lapse fluorescent microscopy requires 
the use of automated image analysis software. Here, we used flow cytometry as a model in the 
analysis and presentation and design of our image analysis program. Initial steps in flow 
cytometry involve establishing acceptable gates to classify events as either noise or cells. In flow 
cytometry, this is accomplished gating the forward and side scatter events. Through observation 
we found that observing the histogram of the size of (PE/red) objects provided a reasonable 
means to distinguish noise and cellular objects. A second important concept in flow cytometry 
involves using controls to determine levels of background fluorescence and non-specific binding. 
Similar to flow cytometry, unstained controls were used to identify a threshold set point (Fig. 
10). Threshold levels were selected on the basis of the point were FITC (green) objects became 
rare events on unstained control samples. Inaccurate threshold set points reveal obvious 
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distortions and noise. Events collected on each image were stored as events on FCS files for flow 
cytometry analysis. Fluorescent intensity was represented as the sum of the positive pixels in the 
image. Similar to adjusting the voltage and gain, each positive annexin pixel was multiplied by a 
constant factor to increase its intensity by an order of magnitude to ease visualization of FCS 
output plots. A typical sample size used in flow cytometry contains 5,000 to 10,000 events. 
However, flow cytometry has the capacity to measure a few thousand rare events in a sample of 
a few million cells. A single well imaged at 9 different locations over a 24hr period at 50-75% 
confluency would generate approximately 30,000 to 40,000 cellular events, resulting in the 
collection of 1,500 events an hour, similar to the normal sampling size of flow cytometry. Unlike 
the large sampling ability of flow cytometry, live-cell microscopy can easily monitor extremely 
low numbers of cells, a useful application in stem cell biology where populations of only a few 
hundred cells can be obtained.   
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Figure 10: Work Flow Comparison between Flow Cytometry and Live Cell Microscopy  
A work flow comparison between flow cytometry and robotic time-lapse fluorescent microscopy 
images analyzed using similar concepts as flow cytometry. (A) In flow cytometry, first cellular 
events are differentiated from noise based on light scattering properties (forward and side 
scatter) that indicate cell morphological properties. Second, background fluorescence levels are 
determined using unstained control samples. This allows a gate to be established to measure 
the fraction of the population positive for a fluorescent signal. (B) We designed automated 
image analysis software that takes thousands of microscopy images, segments the objects, and 
writes each object found on an image as a flow cytometry event on a flow cytometry file. Noise 
is differentiated from cellular events based on the size of the objects. Background fluorescence 
levels are determined using unstained control samples. This allows the fraction of the population 
positive for a fluorescent signal to be measured. 
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3.2.2 Development of Image Analysis Software 
Robotic microscopy can generate tens of thousands of images in one data set. To facilitate the 
image analysis, quantification, and classification of such an enormous number of images, 
automated image analysis software was written using ITK, a C++ image segmentation and 
registration code library. Further to visualize the large number of images, output was written to a 
FCS file format for analysis using flow cytometry software. The program consists of three 
separate parts: The GUI interface, the image processing using ITK, and the C++ program to send 
all output as flow cytometry events to an FCS file format. Image inputs are handled through a 
batch-processing mode. The process is fully automated, and the image analysis parameters can 
be manually adjusted for increased accuracy including the parameters in background 
illumination and object recognition. Output is sent to a tab-delineated text file for data analysis 
using statistical packages and to an FCS file format for analysis with flow cytometry software.  
The image processing is divided into three phrases: the preprocessing, segmentation, and 
analysis of the image. The image is acquired across three channels: PE and FITC fluorescence 
and the light microscopy image. Background illumination on both fluorescent images is removed 
by subtracting a gaussian blur of the respective image. To maximize the sensitivity of detecting 
solid objects, noise or cellular, in the PE channel, an automatic threshold algorithm, the Otsu 
method, is used to select a dynamic threshold set point (Otsu, 1979). After segmentation, each 
object is uniquely labeled using a 4-way connected components filter. In the FITC fluorescence 
channel, an alternative method was used to process the images collected from the FITC 
fluorescent channel to preserve the image intensities to allow for comparison. After the removal 
of background illumination, no further preprocessing was conducted to preserve original pixel 
intensities. Segmentation of objects in the FITC fluorescent channel was conducted using a 
standard binary threshold filter where the threshold set point was determined as based on 
unstained controls.  
After segmentation, each FITC and PE object was assigned a unique label using a 
connected components algorithm, and each object was assessed for a number of different 
parameters including size, the sum of the pixel intensity, and average pixel intensity of the 
object. The fluorescent intensity of an object was defined as the sum of pixel intensities for the 
object. No image processing is applied directly to the light microscopy image, but segmentation 
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results from each of the fluorescent channels are overlaid onto the image to provide a visual 
validation of the accuracy of the analysis (Fig. 10). An important feature of the software is the 
inclusion and distinction between objects classified as either noise or objects. Objects considered 
cells are highlighted with PE pixels while noise is displayed with blue pixels. These can be 
viewed in the supplementary video #1 collected in the example discussed below. 
3.2.3 Proof of Concept – Monitoring Levels of Cell Death 
To test the performance of our software and its comparability to flow cytometry, we exposed a 
primary cell line, myoblasts, to increasing doses of staurosporine (STS) to induce apoptosis and 
cell death. Annexin-V, an early marker of apoptosis, was used to monitor cell death at 6 hour 
time intervals using flow cytometry and on a continual basis using robotic, live cell microscopy. 
Although our methods collects data over a continuous time period, it is impossible to validate 
this method at each time point using flow cytometry. Instead, 6 hour time intervals were selected 
for comparison between the two methods. Example dot plots at 6 hour time intervals over a 24 
hour period are displayed in Fig. 11A and 11B. At each time point, it is possible to observe the 
evolution of a large population of annexin-(+) cells. These results are supported by a series of 
representative annotated output images from these respective time points (Fig. 11C).  
Flow cytometry is a powerful method because of its quantitative ability. Results collected 
using both methods at each 6 hour time point were comparable (Fig. 12). Levels of annexin-(+) 
cells were comparable at low doses of STS, however at the higher doses the fraction of annexin-
(+) cells were consistently higher using flow cytometry. This method involves a substantial 
number of sample manipulations, including harvesting the cells and multiple washes, prior to 
measurement which may increase the damage on an already fragile cell inadvertently increasing 
the fraction of the population positive for annexin-FITC. Cells were harvested using a gentle, 
dilute trypsin wash. Levels of apoptosis were not increased as compared if other harvesting 
approaches were used including gentle washes with EDTA solution.  
An added benefit of conducting these measurements continuously is the ability to observe 
the continual progression of annexin-(+) cells. The quantified results from the direct analysis 
using the FCS formatted files of the live-cell microscopy are shown over time in the 
supplementary video #1. In this example, the morphological changes of the cell can be viewed 
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along with fluorescent intensity changes in each of the input screens while the processed output 
image displays the classification of each of the observed objects. Quantified results show a dose 
response, however the kinetic response at each dose can be seen (Fig. 12). Looking at individual 
time points, 500 and 5000nM STS appeared to have similar levels of cell death (Fig. 12C and 
12D); however the continuous time plot of these doses reveals a trend (Fig. 12E). At 5000nM, 
the cell population had a faster response to STS and maintain a continuously higher fraction of 
annexin-(+) cell fractions. Observing the evolution of annexin-(+) cells over a continuous period 
of time allows trends to be distinguished from noise.  
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Figure 11: Comparison of Flow Cytometry and Live Cell Microscopy Output  
A comparison of output FCS files between flow cytometry and our image analysis software. To 
validate the accuracy of this method, primary satellite cells were exposed to increasing doses of 
staurosporine (STS; 0 to 5000 nM) to induce apoptosis as measured by annexin-V FITC 
expression. (A) Flow cytometry dot plots are shown for each time point. (B) After the image 
analysis, the counted microscopy results are displayed as flow cytometry dot plots at selected 
time points of 6, 12, and 24 hrs. (C) Representative output images at 6, 12, and 18hrs of each 
processed image are annotated denoting cells (PE objects), apoptotic cells (FITC objects), and 
noise (blue and purple objects). Blue objects represent cellular noise and purple objects represent 
annexin-(+) object noise.          
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Figure 12: Comparison of Flow Cytometry and Live Cell Microscopy Apoptosis Fractions.         
Time course comparison of annexin-(+) cell fractions between flow cytometry and the image 
analysis software at increasing doses of STS. (A) At 0 nM STS, measurements collected using 
fluorescence microscopy had a trend of higher levels of cell death, but these differences were not 
significant. (B) Both methods had comparable annexin-(+) cell fractions at 50nm STS. Fractions 
of annexin-(+) cells at 500 and 5000nM STS were higher in the flow cytometry (C and D, 
respectively). These differences were significant at later time periods (P<0.05). The only 
significant differences in measurements at all doses and time points compared occurred in the 
final two 6 hour time points at the two highest doses. (E) The time plot of annexin-(+) cell 
fractions at each point at increasing doses of STS. The cell death profile of each dose contains 48 
data points with 27 separate measurements. The confidence intervals are omitted to increase 
clarity. (F) The two highest doses of STS are highlighted during the early time period to 
demonstrate the ability to distinguish noise from trends. The shaded areas represent the 
confidence interval (CI) at each dose. 
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 3.2.4 Photostability and Validation 
In fluorescence microscopy, prolonged excitation and photoxidation can lead to a decrease in 
fluorescent signal. Next we explored if this loss in fluorescent signal prevented accurate cell 
tracking in both fluorescent channels over extended time periods. Cells loaded with tracking dyes 
experience a natural loss in fluorescent signal due to the diffusion of dye from the cell and from 
cell division. This loss in fluorescence signal can be observed in the representative histograms of 
average pixel intensity of PE objects at the initial 6 hour and final 24 hour periods. These 
histograms were collected from the control groups with no addition of STS and low levels of cell 
death, representing an actively dividing cell population (Fig 13D and E). Box and whisker plots 
used in Figure 13C provided a representation of the dynamic range of fluorescent intensity. The 
fluorescent shift of the entire group occurs in the initial 12 hours.  
To verify that the annexin-V signal did not decrease over time we observed the changes 
in pixel intensity in the dose with the largest annexin-(+) populations in the myoblasts exposed to 
500 and 5000 nM STS. The pixel intensity of objects identified as annexin-positive were 
observed over a prolonged time period and revealed no decrease in intensity (Fig. 13A and 13B). 
The histogram of the average pixel intensity of FITC objects at the initial 6 hrs and final 24 hrs 
revealed that little change occurred in fluorescent intensity. Further, the medians of these 
populations were not significantly different (P=0.56). 
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Figure 13: Photostability and Phototoxicity Concerns  
Both fluorescent dyes maintain the necessary signal strength to be measured. Histograms of the 
average FITC object pixel intensity at 6 hrs (A) and 24hrs (B) reveal no change in intensity 
across 24 hrs. The medians of the average FITC pixel intensity are not significantly different. (C) 
The medians of the average PE pixel intensity are not significantly different, but a box and 
whisker plot reveals an observable shift in intensity. Histograms of the average PE object at 6 hrs 
(D) and 24 hrs (E) pixel intensity also show this shift.  
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3.3 DISCUSSION AND CONCLUSION 
In robotic microscopy, the large data sets present enormous potential and problems. Here, we 
present a new approach to analyze and visualize results from these large image sets. The large 
data sets generated by robotic microscopy require automated image analysis software. ImageA 
counts the number of cells on an image, determines the levels of fluorescence, and allows 
visualization of the output on flow cytometry files.  Here, we demonstrated the utility of this 
software by using STS to induce apoptosis and measured levels of annexin-positive cells over 
time. Direct counting by the software and analysis of the generated flow cytometry output files 
revealed that this approach was comparable to data generated by flow cytometry. Some notable 
advantages and disadvantages exist. Flow cytometry advantages include the ability to scan an 
extremely large population (greater than 1x105 cells) and detect rare events at high speeds and 
quantify multiple fluorescent signals using an array of lasers at specific wavelengths. Our current 
method only demonstrated the use of one fluorescent channel; however the only limit on the 
number of fluorescent signals that can be employed depends on the ability of different signals to 
be distinguished from each other. Further, because measurement of signal intensities on images 
was collected using a fluorescent light source over multiple wavelengths, measurement of signal 
intensity is only pseudo-quantitative. This means that binary decisions such as distinguishing 
fluorescent objects from non-fluorescent objects or bright fluorescent objects from dim 
fluorescent objects could be completed. Our software could not be used to determine differences 
in signal intensities unless properly validated. Flow cytometry can collect data at only one time 
point from adherent cell populations. Sample size using the live cell microscopy depends on the 
number of images collected in each group. In these experiments, both methods had sample sizes 
at each time point on the same order of magnitude. Further, live-cell microscopy has the added 
benefit of following the population over an extended period of time. This permits the long term 
observation of trends using a smaller number of cells. This is especially useful in fields where 
only small populations of cells can be collected, including stem cell biology or working with 
clonal populations of cells. 
Many different technologies and languages exist to conduct image processing or design 
image analysis software. The largest choice is between writing custom built software or using 
image analysis software such as the commercial packages Metamorph, ImageMagik, and 
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Northern Eclipse or open source projects such as ImageJ. Custom built code has the most 
flexibility, functionality, and ability to be modified. It has the least amount of limitations, but has 
the disadvantage of requiring the most technical expertise. We developed custom code for this 
project because the challenges presented by developing this technology required maximum 
flexibility and functionality. Many different image analysis code libraries or packages exist to 
construct code, including writing scripts in the available software or Matlab or writing 
compilable code using the libraries ITK. ITK was chosen because of the advantages of a higher 
computer language including portability, efficiency, and scalability. Because it is composed of a 
large library, multiple options exist to perform a single task. Most importantly, it’s an open 
source library that can be compiled on multiple operating systems with an excellent support 
community.  
Both methods of analysis of the fraction of annexin-positive cells collected using live cell 
microscopy have comparable results to measurements collected using flow cytometry. Some 
important distinctions and similarities exist. In flow cytometry, annexin-positive cells are 
classified based on an object having a fluorescent signal above a specified threshold intensity as 
determined from unstained controls. A similar approach in image analysis is referred to as a 
binary threshold where objects below a given level are classified as background pixels. The 
FITC fluorescent channel is thresholded at a given value based on unstained control cells under 
the same fashion as single parameter controls in flow cytometry. A correct threshold value is 
easy to determine, as low threshold values generate a large volume of noise and above this initial 
value, the measurements are not sensitive. From this perspective, the gate has a binary-like 
behavior. In fluorescence microscopy, noise and cells are distinguished based on the size of the 
objects similar to the forward and side scatter gating used in flow cytometry (Fig. 10A).  
Visual interpretation of time series is typically conducted by displaying the results as a 
movie. This method has a number of disadvantages including the loss of quantitative information 
on the image, and the inability to view an image set consisting of thousands of images. Data 
collected using flow cytometry has a similar problem as high through-put live-cell microscopy. 
Past groups that have worked with high-throughput microscopy have adopted a method used in 
microarrays where data is displayed as a heat map (Bahnson et al., 2005; Perlman et al., 2004). 
In a flow cytometry sample, thousands of events are collected, and measured using an array of 
parameters that describe fluorescent intensities and cell light scattering properties. A unified, 
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standard data file format for flow cytometry, flow cytometry standard (FCS), is used that allows 
data collected on any instrument to be read and analyzed on other computers and software 
(Seamer et al., 1997). This allows a very large data set to be visualized and analyzed from a 
global perspective. Our approach to the analysis of images collected on the microscope is similar 
to the flow cytometry measurement parameters. Following this methods similarity to flow 
cytometry, the collected output is written to the FCS file format for visualization on flow 
cytometry analysis software. Output is also sent to a tab-delineated text file to allow analysis 
using any statistical analysis software. In this study, we used the freely available open source, R-
Project. 
An additional concern in these experiments involved possible toxicity issues from either 
of the fluorescent dyes. However, the low levels of cell death observed using both the live-cell 
microscopy and flow cytometry suggests toxicity is not a major concern (Fig. 12A). These 
results were confirmed with flow cytometry measurements. We cannot completely rule out the 
possibility that these dyes may have made the cells more sensitive to damage and primed the 
cells for cell death at increasing doses of STS. We did observe that higher doses of the PE cell 
tracking dye would raise levels of apoptosis in control groups, highlighting the importance of the 
controls in these experiments.  
An interesting note includes the delay between the change in cell morphology and the 
detection of annexin on the cell surface (Supplementary video #1). At all doses above 50nm 
STS, cells were observed to condense into spherical blobs within an initial 2 hrs after exposure to 
STS. Both flow cytometry and live-cell microscopy did not detect significant levels of annexin-
positive cells until a few hours after this initial observed morphological change. This highlights 
the importance and value of collecting the fluorescent signal over a continuous period of time 
while also observing light microscopy morphology changes.  
We have used open source software and robotic microscopy to monitor annexin-positive 
cell fractions over a continuous period of time. To our knowledge, there is no freely available 
software or open source code that permits output collected from fluorescent microscopy images 
to be analyzed as flow cytometry data. Here, we used STS to induce cell death to monitor 
annexin-positive cell fractions as a proof of concept of the technology we have developed. This 
software has been designed to measure levels of annexin-positive cells, however it is suitable to 
measure any single-parameter fluorescent signal in a live cell microscopy environment providing 
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that it is non-toxic to cells and can maintain a stable fluorescent signal. This includes organic 
fluorophores and fluorescent semiconductor nanocrystals, quantum dots. 
3.4 METHODS 
3.4.1 Cell Culture 
Primary myoblasts used in these experiments were collected using the modified preplate 
technique (Rando and Blau, 1994). Cells were expanded and cultured in proliferation media 
which contained Dulbecco’s modified Eagle’s medium supplemented with 2 mM L-
glutamine,1.0mM sodium pyruvate,10% heat inactivated FBS, 10% horse serum, 1% 
penicillin/streptomycin, and 0.5% chick embryo extract. During experiments, cells were planted 
at 2500 cells/cm2 in either 24 or 48 well collagen coated plates for the live cell microscopy 
assays or in 6 well plates for the flow cytometry measurements. 
3.4.2 Apoptosis 
Flow Cytometry: To determine levels of cell death after exposure to staurosporine (STS; 
Sigma), levels of apoptosis and necrosis were measured using flow cytometry. Myoblasts were 
cultured for 24 hours under normal culture conditions, and then incubated in STS at 37C. For 
flow cytometry measurements, cells were harvested at 6, 12, 18, and 24 hours using a dilute 
trypsin-EDTA solution (0.01%; Gibco Laboratories), and quenched with proliferation media.  
After centrifugation, the cell pellet and collected media was stained with annexin-V FITC 
according to manufacturer’s directions (BD Bioscience).  Flow cytometry measuremenst were 
collected on a FACSCaliber (Becton Dickenson) with standard calibration and one color control 
for compensation of fluorochromes and analyzed using FlowJo (Treestar, Inc.).        
Live Cell Microscopy: Live cell microscopy was conducted using a robotic, automated 
imaging system (Automated Cell, Inc.). The cell culture imaging system consists of an 
environmentally controlled biochamber that maintains a humidified, 37°C atmosphere at 5%CO2 
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mounted on an inverted fluorescent microscope (Nikon TE 300) with electronically controlled x-
y motorized stage (Ludl Electronics, Ltd.) and a motorized focus. The stage can return to each 
location on a stage with a repeatability of ±1.5µm (Bahnson et al., 2005). Images were acquired 
using the 20x objective with a total of 200x magnification on a Nikon TE300 inverted 
microscope with a Photometrics SenSys high resolution (7 x 9 mm, 1036 x 1318 pixel chip) 
CCD camera (Roper Scientific). Exposure for all images in the PE fluorescent channel was set at 
400ms and at 550ms for the FITC fluorescent channel. The biochamber, microscope, and image 
acquisition system was controlled using Data Collector™ (Automated Cell, Inc). Image analysis 
was conducted using custom built software as described below.        
Images were acquired on a 30 minute interval for a continuous 24hr period on 24 or 48 
well plates. The plate layout included triplicate wells for each group tested, and 9 locations were 
monitored in each well. Each group had approximately 1,300 images in a 24 hour period. To 
allow fluorescent segmentation of live cells, myoblasts were loaded with 10µM cell tracker red 
CMTPX (Molecular Probes), for 1.5hrs, washed in PBS, followed by incubation in culture 
medium for an additional 1.5hrs, and a final wash in PBS. Levels of cell death were monitored 
by adding 100µg/mL of Annexin-V FITC (BD Clontech) to each well. After an initial set of 
images at each location in the well were acquired, apoptosis was induced using increasing doses 
of staurosporine.   
3.4.3 Software 
The custom designed software used to analyze the images collected from the automated 
microscopy contains three separate pieces: the GUI, image analysis, and output formatting. Each 
component of the image analysis software used in this project are open-source. The GUI was 
written using the QT (version 3.2; Trolltech) a C++ library available under the GNU GPL license 
available for download (http://www.trolltech.com/download). The image analysis was conducted 
using the Insight Toolkit (ITK) an open source C++ software library for image segmentation and 
registration available for download (http://www.itk.org)(Yoo et al., 2002).  Both of these toolkits 
can be compiled on Windows, Apple, and Linux. Output from each image were sent to a tab-
delineated text file for statistical data analysis, and later converted to an FCS file format (Seamer 
et al., 1997) for analysis on the flow cytometry software FLowJo. Similar to flow cytometry, 
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each object on an image was considered an event. The measurements associated with each event, 
which roughly corresponds to a cell,  were outputted to the flow cytometry standard data storage 
(FCS) version 3.0 file format (Seamer et al., 1997). This permitted the image processing 
measurements to be compared to flow cytometry measurements.  
The executable files, example images, and the source code are available for download at 
www.imageK.org, and permanently archived with a digital handle using the Insight Journal, an 
online, open-peer reviewed journal (http://www.InsightJournal.org/).   
 
3.4.4 Data Analysis and Statistics 
All statistical analysis was performed using the open source statistical and data analysis 
programming environment, R-Project (Team, 2006). Flow cytometry and microscopy data 
formatted into the FCS file format were analyzed using FlowJo (TreeStar, Inc.).  
 
 39 
4.0  ANTIOXIDANT CAPACITY IN MDSC BASED CELL THERAPIES 
4.1 INTRODUCTION 
Myogenic cells have been proposed as cell sources for both skeletal and cardiac muscle 
cell based therapies. Diseased myocardial tissue has a limited ability to regenerate, leading to 
eventual heart failure. As an alternative to heart transplantation, numerous groups have proposed 
using different cell types as an exogenous source of cells for transplantation into failing heart 
tissue to improve performance. Similar approaches have been pursued as treatments in muscular 
dystrophies. Myogenic cells are the fundamental building blocks of a mature skeletal muscle 
fiber, and are a natural choice in developing a cell therapy treatment. 
A major obstacle in both of these therapies is the loss of the majority of transplanted 
myoblasts shortly after transplantation. This has been documented in cardiac cell transplantation, 
but closely studied following skeletal myoblast therapies. In skeletal muscle myoblast 
transplantation, an inflammatory response was observed shortly after injection (Beauchamp et 
al., 1994; Beauchamp et al., 1999; Fan et al., 1996; Gussoni et al., 1997; Gussoni et al., 1992; 
Karpati et al., 1993; Mendell et al., 1995). Various groups have postulated that the small number 
of injected myoblasts that survive the transplantation in both cardiac and myoblast 
transplantation may be a special subpopulation of cells (Beauchamp et al., 1999; Oshima et al., 
2005; Qu et al., 1998; Urish et al., 2005).  
The preplate technique was originally developed to isolate myoblasts from the 
fibroblasts, endothelial, and adipogenic tissue of whole tissue preparations based on the non-
myogenic tissue cell types greater adherence to the bottom of a cell culture flask (Jankowski et 
al., 2002a; Lee et al., 2000; Qu-Petersen et al., 2002). Our group modified this technique to 
isolate various populations of myogenic cells, including quiescent and activated satellite cells 
and MDSCs, based on adherence to collagen coated flasks. This final population, MDSCs, 
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appears to be an early progenitor population of myogenic cells based on the cells’ scarcity in 
muscle tissue and absence of the myogenic markers, including MyoD. There were three unique 
features with this cell population. First, MDSCs can differentiate into multiple lineages including 
muscle, bone, epithelial, neural, and hematopoietic lineages (Urish et al., 2005). Second, the cells 
show multiple signs of long term self-renewal (2005; Deasy et al., 2005; Qu-Petersen et al., 
2002). More importantly, when transplanted into skeletal muscle, MDSCs have a superior ability 
to regenerate skeletal muscle compared to myoblasts (Lee et al., 2000; Qu et al., 1998; Qu and 
Huard, 2000). Similar results were observed in cardiac cell therapies; MDSCs had superior 
engraftment and functional improvement compared to transplanted myoblasts (Oshima et al., 
2005).  
A major unanswered question has been identifying the attributes that give MDSCs a 
superior ability to repair tissue compared to myoblasts. Stem cells are defined by their ability to 
differentiate into multiple tissue types and their ability to self-renewal. MDSCs distinct 
phenotype of relatively high levels of proliferation, a propensity for continued self-renewal, and 
the ability to act as a single unit capable of regenerating all the different cell types necessary for 
functional muscle, is a unique property that has been reported to be important in muscle 
regeneration. However, the dominant role of cell survival in both of these cell transplantations 
suggests that other factors are important. 
The rapid, large-scale initial cell death and presence of inflammation at the site of 
transplantation in both skeletal muscle therapies suggests that oxidative stress may play an 
important role in the transplantation process(Urish et al., 2005). Oxygen is part of the crucial step 
in cellular respiration because of its strong ability to strip and accept electrons from other 
molecules, however this property is also inherently dangerous to the cell. The destructive power 
of oxygen is a major component of inflammation. Ischemia and the associated reperfusion injury 
is directly linked to the production of various reactive oxygen species (ROS) (Ambrosio and 
Tritto, 1999; Carden and Granger, 2000; Zhao, 2004). After cell transplantation, the mechanical 
perturbation of the microvascular barrier results in the recruitment of inflammatory cells (mainly 
neutrophils and monocytes) and in further ischemia (Carden and Granger, 2000; Gute et al., 
1998). The induction of oxidative stress leads to the generation of proinflammatory cytokines, 
including TNF-α, and the ischemia both directly result in oxidative stress (Dhalla et al., 1999; 
Gute et al., 1998). From this perspective, one of the main outcomes of oxidative stress is the 
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ensuing inflammatory stress and its associated cytokine storm of TNFα, IL-1, and IL-6. 
Oxidation is the primary factor responsible for the destruction of protein, lipids, and DNA. It has 
been shown that inflammation and the associated release of pro-inflammatory cytokines leads to 
oxidative stress at the local microenvironment after multiple types of cell transplantation, 
including myoblast transplantation into skeletal and cardiac muscle, transplantation of pancreatic 
islets, and bone marrow transplantation (Bertera et al., 2003; Blackwell et al., 2000; Bloch and 
Vardi, 2005; Bottino et al., 2002; Bottino et al., 2004; Evens et al., 2004; Guerette et al., 1997a; 
Guerette et al., 1997b; Qu et al., 1998; Suzuki et al., 2004; Suzuki et al., 2000).  
Here, we compared the ability of MDSCs and myoblasts to resist inflammatory an 
oxidative stress and the role this played in the regenerative capacity of the cells in vivo. We 
hypothesized that the inflammatory response observed at the site of transplantation is a factor in 
the large differences observed in the engraftment capacity of MDSCs and myoblasts. Our 
primary objective was to determine if a phenotypic resistance to stress could be observed 
between the two cell populations including survival, differentiation, and antioxidant capacity. 
We also documented differences in cellular damage following exposure to oxidative stress. We 
then investigated if any of these differences could alter the regenerative capacity of the cells in 
vivo.    
 
4.2 RESULTS 
4.2.1 MDSCs Have Lower Levels of Oxidative and Inflammatory Stress Induced Cell 
Death and Apoptosis 
MDSCs have demonstrated an increased regenerative capacity in both skeletal and myocardial 
muscle (Oshima et al., 2005; Qu-Petersen et al., 2002; Urish et al., 2005). Further, multiple 
groups have demonstrated a large inflammatory response at the site of both these types of 
transplantation (Bertera et al., 2003; Blackwell et al., 2000; Bloch and Vardi, 2005; Bottino et 
al., 2002; Bottino et al., 2004; Evens et al., 2004; Guerette et al., 1997a; Guerette et al., 1997b; 
Qu et al., 1998; Suzuki et al., 2004; Suzuki et al., 2000).  Oxidative stress is a potent stimulant 
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and amplifies the inflammatory response via nuclear factor kappa B (NFκB) signaling. We 
hypothesized that MDSCs may have an increased regenerative capacity because of an increased 
resistance to oxidative stress and the following inflammatory response. To test this hypothesis, 
myoblasts and MDSCs were exposed to increasing doses of H2O2 and TNFα to determine if 
MDSCs had a survival advantage after exposure to stress. 
Each cell population was exposed to increasing doses of H2O2 (Fig 14). At each dose, 
MDSCs had lower levels of apoptosis than myoblasts. MDSCs had slightly higher levels of 
necrosis, but this was a minor fraction of the total cell death. These results suggested that 
apoptosis is the dominant form of cell death, and that MDSCs have an increased resistance to 
oxidative stress induced apoptosis. A limiting factor in these experiments was the ability to only 
collect a limited series of measurements at one time point.    
Our group has adapted a robotic, live-cell microscopy system to measure levels of 
annexin-positive cells over an extended and continuous time period. Using this approach, it was 
possible to screen a larger number of doses of H2O2 over a continuous time period instead of a 
limited number of doses at a single time point. MDSCs consistently had lower levels of cell 
death as compared to myoblasts as both populations were exposed to a range of H2O2 (Fig. 14D-
H). A summary of these results at 18hrs is included to allow a comparison to results collected 
using flow cytometry (Fig. 14C). Except at the highest dose of H2O2, these results were 
comparable. However, Figure 14H suggests that the H2O2 concentration was approaching a level 
where MDSCs ability to dissipate H2O2 was finally overwhelmed to a similar degree as 
myoblasts.  
Similar results were observed when both cell populations were exposed to increasing 
doses of the inflammatory cytokine TNF-α. Physiologic concentrations of TNF-α operate in the 
range of 1 to 5ng/mL. After approximately 18 hrs, myoblasts had significantly higher levels of 
cell death at all doses (Fig. 15). Together, these results suggested that MDSCs possessed a 
resistance to stress induced apoptosis. These results were significant, but were not as dramatic as 
the differences seen between the two cell populations regeneration capacity. This led us to 
investigate if oxidative and inflammatory stress would alter the levels of differentiation in the 
two cell groups.  
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Figure 14: MDSCs have lower levels of cell death following exposure to H2O2.  
Myoblasts and MDSCs were cultured for 18hrs in increasing doses of H2O2, and the levels of 
apoptosis (A) and necrosis (B) were measured using flow cytometry with Annexin-V and 
propidium iodide staining. MDSCs had lower levels of apoptosis at all doses (P<0.05). 
Myoblasts and MDSCs had significantly higher levels of apoptosis than untreated controls 
(P<0.05). Myoblasts had significantly lower levels of necrosis than MDSCs (P<0.05), however 
MDSCs levels of necrosis were not significantly higher than untreated controls (P=0.07). 
Further, comparing the two different types of cell death, apoptosis was the dominant form. An 
automated live-cell microscopy method was used to monitor levels of Annexin-V staining over a 
36hr period in myoblasts and MDSCs at 10 (C), 25(D), 50(E), 100(F), 250(G), or 500µM H2O2 
(I). Data points were collected every 30 min, and include 27 different measurements in each 
group. In the plots of C-I, the solid lines represent the mean fraction of annexin-positive cells. 
The range-plot represents the 95% confidence interval (CI) of these measurements. Statistical 
analysis was performed using ANOVA.      
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Figure 15: MDSCs have lower levels of cell death following exposure to the inflammatory 
cytokine TNF-α.  
An automated live-cell microscopy method was used to monitor levels of annexin-V staining 
over a 36hr period in myoblasts and MDSCs at 1.0(B), 2.5(C), and 5.0 ng/mL TNF-α (D). A 
summary of these results at 18 hours are included (A). Data points were collected every 30 min, 
and include 27 different measurements in each group. The solid lines represent the mean fraction 
of annexin-positive cells. The range-plot represents the confidence interval of these 
measurements. Data points in each cell group were collected every 30 min, and each data point 
contains 27 independent measurements. As a result, the mean annexin-positive cell fraction is 
plotted as a line, but the 95% confidence interval (CI) of this line is plotted as a range. This is 
possible because of the large number of measurements at each of the numerous data points. 
ANOVA was performed at 18 hrs to determine significant differences (P<0.05).  
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 4.2.2 MDSCs Maintain the Ability to Differentiate After Oxidative Stress. 
Cell survival is one phenotype that may confer an advantage in muscle repair; however 
the ability of a cell population to successfully differentiate is also important. As a result, the 
ability of MDSCs and myoblasts to differentiate, fuse, and form myotubes after exposure to 
oxidative and inflammatory stress was investigated. After culture in low serum media to induce 
differentiation, cells were temporarily exposed to increasing doses of H2O2 and TNF-α. 
Differentiation was measured as a function of the fusion index, the ratio of nuclei colocalized 
with myosin heavy chain, a late differentiation myogenic protein. At day 3, large differences 
between the ability of MDSCs and myoblasts to form myotubes after exposure to oxidative and 
inflammatory stress were observed. At increasing doses of H2O2, the fusion index of MDSCs 
remained constant, however myoblasts had a progressive dose response decrease in their fusion 
index. These responses were temporary, and at day 4 both groups had similar levels of fusion 
(Fig 16). An identical response was measured when both cell populations were exposed to TNFα 
(Fig 17). These results demonstrated that MDSC differentiation was not inhibited by these 
oxidative or inflammatory stresses, but that myoblast differentiation was only temporarily 
sensitive to this stress.    
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Figure 16: Oxidative stress delays differentiation in myoblasts but not in MDSCs.  
Immediately after cultures were exposed to low serum fusion conditions, increasing doses of 
H2O2 were added to the media to induce oxidative stress. After a two day period, this media was 
replaced with fresh low serum media. Differentiation was monitored by measuring the fusion 
index – the ratio of nuclei associated with the late fusion myogenic protein, myosin heavy chain 
(MHC). (A) At day 3, MDSCs exposed to different doses of H2O2 had similar levels of fusion as 
untreated controls. However, myoblasts treated at all doses of H2O2 had significantly lower levels 
of fusion than untreated controls (*P<0.05). Myoblasts treated at the highest dose of H2O2 had 
significantly lower levels of fusion than myoblasts treated at the lowest dose, revealing a dose-
dependent response (*P<0.05). (B) Representative images of MDSCs and myoblasts exposed to 
0 and 100µM of H2O2 at day 3. (C) At day 4, myoblasts and MDSCs exposed to H2O2 were not 
significantly different than untreated controls. (D) Representative images of MDSCs and 
myoblasts exposed to 0 and 100µM of H2O2 at day 4. 
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Figure 17: TNF-α delays differentiation in myoblasts, but not in MDSCs. 
The fusion index of myoblasts and MDSCs treated with increasing doses of TNF-α were 
measured. (A) At day 3, myoblasts treated with all doses of TNF-α had significantly lower levels 
of fusion than untreated controls (*P<0.05). Myoblasts treated at the lowest dose of TNF-α, 
1.0ng/mL, had significantly higher levels of fusion than the other two lower doses revealing a 
dose-dependent response (*P<0.05). At day 3, TNF-α did not alter the levels of fusion of 
MDSCs. (B) Representative images of MHC expression between MDSCs and myoblasts at day 
3. (C) At day 4, TNF-α did not alter the fusion index of myoblasts and MDSCs. (D) 
Representative images of MHC expression are shown between myoblasts and MDSCs.  
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 4.2.3 Myoblasts Have Higher Oxidative Damage from Increased Intracellular ROS. 
MDSCs had lower levels of cell death and maintained their ability to differentiate as compared to 
myoblasts after exposure to oxidative and inflammatory stress. We hypothesized that these 
phenotypic differences extended from higher levels of oxidative damage in myoblasts following 
exposure to oxidative stress. Damage from increased levels of intracellular reactive oxygen 
species (ROS) can be assessed by measuring oxidative protein, lipid, or DNA damage. 
Therefore, we first measured levels of intracellular ROS in both cell populations following 
exposure to a high dose of H2O2 using the fluorescent indicator carboxy-H2DCFDA (Fig. 18A 
and 18B). At the maximum levels of ROS, MDSCs had essentially no measurable level as 
compared to the high level of ROS measured in myoblasts. Oxidative damage to proteins was 
monitored following exposure to multiple doses H2O2. Densitometry analysis revealed that 
MDSCs had lower levels of oxidative protein damage than myoblasts at respective doses (Fig. 
18C). Although, these differences were not statistically significant, the same trend was measured 
in three separate experiments.  
4.2.4 MDSCs Have Increased Protection from Reactive Oxygen Species 
Increased levels of ROS and oxidative damage imply that MDSCs have higher levels of 
antioxidant activity to defend against redox imbalances. The two major cellular antioxidants are 
glutathione (GSH) and the multiple types of superoxide dismutase (SOD). Basal concentrations 
of reduced glutathione (GSH) were measured using flow cytometry analysis following staining 
with monochlorobimane (MCB). The histogram plot of both cell groups reveal that the MDSCs 
have a shifted peak compared to myoblasts, but also shows that MDSCs have a skewed 
distribution towards that higher intensity of fluorescence (Fig. 18D). Mean fluorescence reveals 
that the differences in GSH levels are significant (Fig. 18E). Total SOD activity was measured 
between both cell groups using a colorimetric assay. Similar to GSH levels, MDSCs had higher 
levels of total basal SOD activity (Fig. 18F). 
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Figure 18: MDSCs have lower levels of oxidative damage and a higher antioxidant capacity 
than myoblasts. 
Both cell populations were exposed to 100µM H2O2 for 24hrs. (A) Intracellular levels of ROS 
were measured in the initial 2hr period following exposure to 500µM H2O2. MDSCs had little 
increase in ROS while myoblasts had a large increase in intracellular ROS at 30 min. (B) The 
differences observed at 30 min were significant (*P<0.05). (C) Both cell populations were 
exposed to multiple doses of H2O2 up to 100µM for 24hrs, and levels of protein oxidative 
damage were measured. Protein oxidative damage was measured using DNPH-derivitization, 
probing with appropriate antibodies, and conducting electrophoresis. Densitometry of the results 
shoed myoblasts had higher levels of oxidized protein damage, but these difference were not 
significant. (D) Both populations were stained with MCB to determine levels of GSH, an 
important cellular antioxidant. The flow cytometry histogram revealed that MDSCs had a shifted 
and skewed population density to higher levels of GSH. (E) The mean of the fluorescent 
intensity of the histogram peaks are shown (*P<0.05). (F) MDSCs had a significantly higher 
total activity level of SOD (P<0.05). 
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4.2.5 Decreasing the MDSCs Resistance to Stress Dramatically Decreases the 
Regeneration Capacity of MDSCs 
Compared to myoblasts, MDSCs increased antioxidant capacity prevents oxidative and 
inflammatory stress induced apoptosis or a decrease in differentiation. To assess the role this 
antioxidant capacity plays in vivo, we performed a series of experiments to inhibit the MDSCs 
resistance to oxidative stress and measure any possible change on the level of regeneration. 
Diethyl maleate (DEM) is a specific, non-protein thiol-depleting agent that selectively inhibits 
glutathione activity (Plummer et al., 1981) In initial experiments, the basal levels of GSH were 
measured following exposure to increasing doses of DEM. Levels of either 50 or 100 µM of 
DEM were found to sufficiently lower levels of MDSC GSH to levels comparable to those of 
myoblasts (Fig. 19A). Further, MDSCs were exposed to multiple doses of DEM, and levels of 
apoptosis and changes in differentiation were compared to untreated MDSCs and myoblasts. At 
100µM of H2O2, MDSCs exposed to 50µM DEM had similar levels of cell death and changes in 
fusion as compared to the myoblast population (Fig. 19B). Thus, 50µM of DEM was selected as 
an appropriate dose to inhibit the MDSCs resistance to oxidative stress and make the MDSCs 
comparable to myoblasts.  
To determine the role oxidative stress plays in dystrophin-positive myofiber regeneration, 
equal numbers of untreated MDSCs and MDSCs treated with 50µM of DEM were injected into 
the gastrocnemius of dystrophin deficient mdx mice (MDSCs treated with DEM, n=8; untreated 
MDSCs, n=8; untreated myoblasts, n=8). After two weeks, the regeneration index (number of 
dystrophin-positive myofibers normalized to 1x105 injected cells) was measured. On 
observation, MDSCs contained much larger dystrophin-positive myofiber engraftments than 
MDSCs treated with DEM (Fig. 19C). When the engraftments were analyzed, MDSCs treated 
with DEM produced dystrophin-positive engraftments significantly smaller than untreated 
MDSCs and comparable to myoblasts (Fig. 19D; MDSC vs myoblast, P<0.05; MDSC+DEM vs 
myoblast, P=0.072; MDSC vs MDSC+DEM, P<0.05). When antioxidant levels are similar 
between the two cell populations, the ability to regenerate dystrophin-positive myofibers is 
comparable.  
These results suggest that a cell’s antioxidant capacity and the ability to dissipate 
oxidative stress is a major phenotype important in the regenerative capacity of a cell. This 
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hypothesis was tested in a second type of regenerative therapy. Myoblasts have been used in 
multiple clinical trials as a cell therapy to preserve cardiac function following myocardial 
infarctions. To assess if MDSCs antioxidant capacity played a role in cardiac cell therapies, the 
right main coronary artery was permanently ligated to induce a myocardial infarction in adult 
wild-type C57 mice, and cells were transplanted immediately after ligation (MDSCs+DEM, n=8; 
MDSCs, n=7; PBS control, n=8). Histological analysis was completed at 8 weeks, and confirmed 
the myocardial infraction and resulting fibrosis (Fig 20A-C). To compare left ventricle (LV) 
function and remodeling, echocardiography was performed at 6 weeks after infarction. No 
differences in LV cavity size were observed between all three groups as assessed by end-
diastolic area (EDA; data not shown). Systolic function was also assessed by measuring the 
fractional area change (FAC) (Fig. 20D). Both cell treatment groups showed significantly better 
systolic function relative to that of the PBS control group (MDSC vs myoblast, P<0.05; 
MDSC+DEM vs PBS, P<0.05). However, MDSC showed significantly better systolic function 
than MDSC treated with DEM (MDSC vs MDSC+DEM, P<0.05).   
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Figure 19: Decreasing the levels of GSH in MDSCs decreases the ability of MDSCs to 
regenerate dystrophin-(+) myofibers. 
Decreasing the levels of GSH in MDSCs decreases the ability of MDSCs to regenerate 
dystrophin-(+) myofibers. A series of experiments were conducted to identify the appropriate 
dose of DEM that would decrease the antioxidant capacity of MDSCs to comparable levels of 
myoblasts. (A) The histogram plots of GSH levels of MDSCs treated with increasing doses of 
DEM and untreated myoblasts. (B) The levels of cell death of MDSCs treated with 50 µM DEM 
and untreated myoblasts after exposure to 100µM H2O2. The area associated with each line 
represents the 95% confidence interval (CI) of the respective mean. As a reference, levels of cell 
death of untreated MDSCs exposed to 100µM H2O2 are shown. The CI of this line is not 
included to increase clarity. After these two experiments, a dose of 50µM of DEM was selected 
to decrease the antioxidant capacity of MDSCs to levels comparable to myoblasts. MDSCs 
treated and untreated with 50µM of DEM were injected into the skeletal muscle of the mdx mice 
(n=8), sacrificed at 2 weeks, and the regeneration index measured. (C)Treated MDSCs had 
significantly lower regeneration indexes as compared to untreated MDSCs and similar levels of  
regeneration index as compared to myoblasts (*P<0.05). Representative images of the 
dystrophin-positive engraftments of MDSCs (D) and myoblasts (E) are shown. 
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Figure 20: Decreasing the levels of GSH in MDSCs decreases the ability of MDSCs to 
improve cardiac function following induced myocardial infarction. 
Cardiac section from induced myocardial infarctions reveal areas of fibrosis in (A) PBS control 
(B) MDSCs treated with 50µM DEM (C) MDSCs. Echocardiography was used to measure the 
fractional shortening (D) and fractional area change (E) of the three groups. MDSCs had 
significantly higher changes in FS and FAC than MDSCs treated with DEM or the PBS control. 
MDSCs treated with DEM only had significantly higher FAC than the PBS control (P<0.05).. 
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 4.3 DISCUSSION AND CONCLUSION 
Multiple cell populations have been investigated in clinical and preclinical trials for dystrophic 
and cardiac muscle cell therapies. In this study, we have investigated the possible role of a stem 
cell’s antioxidant capacity in its regenerative capacity. Previous reports have shown that MDSCs, 
an early myogenic progenitor cell population, have a superior ability to regenerate dystrophin-
positive myofibers in dystrophic skeletal muscle as compared to myoblasts. Additional studies 
have shown that similar patterns exist in the myocardial infarct model; transplanted MDSCs have 
an improved ability to increase functional recovery of myocardial muscle following an induced 
ischemic episode as compared to myoblasts. Here, we have demonstrated a possible explanation 
outlining these differences in the regenerative capacity of the two myogenic cell populations. 
MDSCs have shown decreased levels of oxidative stress induced apoptosis while myoblasts have 
shown a decreased ability to differentiate following these same conditions. These differences can 
be explained by a protection against oxidative damage. Myoblasts showed higher levels of 
reactive oxygen species, oxidative protein damage, and oxidative lipid damage following 
exposure to oxidative stress. These levels of damage appear to be higher in myoblasts as 
compared to MDSCs because myoblasts have lower levels of GSH and SOD. Finally, when 
MDSC levels of GSH are reduced to similar levels as myoblasts, MDSC have a dramatic 
decrease in the ability to regenerate dystrophin-positive myofibers in skeletal muscle and in the 
functional ability of ischemic myocardial muscle.  
Myoblasts and MDSCs can be isolated based on their differential adhesion 
characteristics, and distinguished based on varying degrees of myogenic commitment and 
regeneration capacity. Myoblasts isolated by their early adhesion to culture flasks have express 
high levels of the myogenic markers desmin and pax-7, and a decreased ability to regenerate 
dystrophin-positive myofibers in dystrophic muscle. In contrast, MDSCs are isolated by their late 
adhesion to culture flasks, and have low levels of expression of myogenic markers, suggesting 
that they are less differentiated myogenic precursor (Urish et al., 2005). The most notable 
difference between these two populations is their dramatic difference to regenerate skeletal and 
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cardiac muscle. In the dystrophic animal model of Duchenne Muscular Dystrophy, the mdx 
mouse, MDSCs have been shown to have an increased ability to regenerate dystrophin-positive 
myofibers when injected in skeletal muscle(Deasy et al., 2005; Lee et al., 2000; Qu-Petersen et 
al., 2002; Urish et al., 2005). Following induced ischemic myocardial infarctions in the murine 
animal model, a similar pattern was found; MDSCs had an improved ability to restore functional 
recovery as compared to myoblasts (Oshima et al., 2005). 
Several studies have reported that a large percentage of cells die in the short time period 
after transplantation into both skeletal and myocardial muscle. In skeletal muscle myoblast 
transplantation, initial work revealed that a large majority of transplanted cells were lost in the 
initial 24hrs (Beauchamp et al., 1994; Fan et al., 1996; Huard et al., 1994a), and long term 
analysis showed that less than 5% of the total number of injected cells survive transplantation 
after one month (Beauchamp et al., 1999; Gussoni et al., 1997; Gussoni et al., 1999; Karpati et 
al., 1993). In the heart, multiple types of transplanted cells have a large percentage of cells that 
die shortly after transplantation including myoblasts (Menasche, 2004; Suzuki et al., 2000; 
Taylor et al., 1998), cardiomyocytes (Zhang et al., 2001), hematopoietic stem cells (Balsam et 
al., 2004, Murry et al., 2004), and mesenchymal stem cells (Mangi et al., 2004). MDSCs have 
been described as a unique cell population because of their ability to avoid this initial pitfall 
following transplantation in skeletal muscle (Qu and Huard 2000; Qu et al., 1998; Qu-Petersen et 
al., 2002) and myocardial muscle (Oshima et al., 2005).  
A large initial loss of transplanted cells strongly suggests a primary non-function 
mechanism from damage occurring during either the pre or post transplantation process. In 
pancreatic islet transplantation, oxidative stress from the transplantation process prior to 
implantation results in a large decrease in yield of functional islets (Bottino et al., 2004). At the 
site of skeletal myoblast transplantation, an acute inflammatory response occurs (Urish et al., 
2006). Similarly, a rapid and strong inflammatory process is the pathologic hallmark after a 
myocardial infarction. A major source of the destructive power of inflammation is the direct and 
indirect generation of reactive oxygen species and free radicals from the release of cytokines and 
interleukins. Together, this suggests that MDSCs may overcome this initial cell loss from having 
an increased resistance to oxidative stress. 
If multiple groups have demonstrated an inflammatory response at the site of skeletal and 
myocardial engraftment, we postulated that perhaps one of the mechanisms behind MDSCs 
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superior regenerative capacity as compared to myoblasts might involve a resistance to this stress. 
In our initial investigation, we attempted to characterize any differences in the phenotypic ability 
to resist stress between these two cell populations, namely by measuring levels of survival and 
differentiation after exposure to stress. Myoblasts consistently had higher levels of cell death 
following exposure to both H2O2 and TNF-α (Fig 16 and 17).These results demonstrated that 
MDSCs, at a minimum, handled oxidative stress and inflammation differently than myoblasts. 
However, although promising, these differences were not enough to convince the authors that 
MDSCs survival advantage over myoblasts entirely explained the observed regenerative 
differences between the two cell populations. Next, we investigated if oxidative stress and 
inflammation altered levels of fusion and differentiation. 
MDSCs had no change in the ability to fuse and form myotubes after exposure to 
inflammatory stress. Myoblasts exposed to increased levels of oxidative stress and inflammatory 
cytokines had a temporary decrease in the ability to differentiate, and when this stress was 
removed, myoblasts resumed differentiation (Fig 16 and 17). These effects could be extended if 
myoblasts were continually exposed to TNF-α (Fig 17). This is an important note because 
different groups have reported that oxidative stress can either induce a “differentiation check 
point” (Puri et al., 2002) or permanently force a cell into a state of senescence (Stoeber et al.,  
2004). A “differentiation check point” is similar to a cell cycle check point in that cell division or 
differentiation is arrested until the damage has been repaired and the stress has been removed. 
The temporary arrest of cell differentiation that we observed has been previously described. 
Multiple groups have observed that myogenic differentiation is inhibited after exposure to the 
inflammatory cytokines TNF-α or IL-1 through activation of the nuclear factor kappa B (NF-κB) 
pathway (Langen et al., 2004; Langen et al., 2001; Guttridge et al., 2000). Other groups have 
shown that direct exposure to oxidative stress inhibits myoblast differentiation through the same 
NF-κB mechanism (Catani et al., 2004). This previous work supports our observations, but also 
suggests a more direct molecular mechanism of MDSCs’ improved regenerative capacity. If 
myoblast differentiation is inhibited via the NF-κB pathway, this implies that MDSCs maintain 
normal levels of differentiation after exposure to stress because they avoid NF-κB activation. 
Indeed, preventing this pathway’s activation has been shown to have a remarkable improvement 
on pancreatic islet transplantation (Bottino et al., 2004). Finally, the continued ability to inhibit 
myoblast differentiation implies that a sustained inflammatory response will prevent myoblast 
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differentiation. This is a possible major component of the mechanism for the observed 
differences in regenerative capacity between MDSCs and myoblasts.  
The phenotypic differences in survival and differentiation could be explained by the 
antioxidant capacity of each population. The two major components protecting a cell from 
oxidative damage include GSH and SOD. MDSCs had increased levels of both of these 
components. The increased protection from ROS in the MDSC population resulted in lower 
levels of intracellular ROS and oxidative protein damage following exposure to oxidative stress 
(Fig. 18). Other progenitor and stem cell populations have been reported to have increased 
antioxidant capacity (Dernbach et al., 2004; He et al., 2004). These groups have shown that 
increased expression of manganese SOD was primarily responsible for an increased resistance to 
stress. Our study was not designed to identify a single factor responsible for the increased 
resistance to stress, but did demonstrate that increased expression of multiple antioxidant species. 
Further, it ahs been demonstrated that depleting levels of GSH in myoblasts has been shown to 
increase NF-κB activation and inhibit myogenesis supporting a possible link as discussed above 
(Ardite et al., 2004). It appears that both antioxidant compounds have demonstrated a 
contribution to improving a cells resistance to inflammation.    
The finding that a population of stem cells has increased resistance to oxidative stress has 
been described to different degrees in the past (Dernbach et al., 2004; He et al., 2004). Other 
studies have implied the importance of stress in the transplantation process by genetically 
engineering the transplanted cell population with protection against inflammation and stress, 
most notably with heat shock proteins. However, no previous work has been completed that 
directly outlines the role that a phenotype of increased resistance to redox stress plays in 
regeneration capacity of transplanted cells in vivo to the authors’ knowledge. 
If MDSC’s antioxidant capacity played an important role in their ability to regenerate 
dystrophin-positive myofibers and improve cardiac function, we reasoned that removing this 
protection should decrease the cell population’s regenerative capacity. MDSCs had higher levels 
of both antioxidants, however there appeared to be a much greater difference in levels of GSH. 
DEM is a GSH depleting agent that conjugates with GSH and further removes it by the GSH-S-
transferase catalyzed reactions. These effects are only temporary as the cell’s machinery to 
regenerate GSH is still functional. We used DEM to decrease levels of GSH in MDSCs to 
similar levels as myoblasts. To verify that MDSCs did indeed have a similar resistance to stress, 
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we confirmed that MDSCs treated with the titrated dose of DEM gave them similar levels of 
survival and differentiation after exposure to a fixed dose of H2O2 (Fig 19). After a dose of DEM 
was identified that decreased the antioxidant protection of MDSCs to similar levels of myoblasts, 
we compared changes in the regenerative capacity of the cell population. In dystrophic skeletal 
muscle, MDSCs treated with DEM had comparable levels of regeneration as myoblasts and 
decreased levels of regeneration as untreated MDSCs. In ischemic cardiac tissue, MDSCs treated 
with DEM had less functional improvement than MDSCs. Levels of improvement of the MDSC 
group treated with DEM were comparable to previous reports of the limited improvement of 
myocardial function obtained transplanting myoblasts into the ischemic area. 
4.4 METHODS 
4.4.1 Cell Isolation and Culture 
Myoblasts and MDSCs were prepared using a modified version of the preplate technique from 
three week C57 mice (Qu et al., 1998; Qu and Huard, 2000; Rando and Blau, 1994; Richler and 
Yaffe, 1970). All cells were cultured and expanded in proliferation media which contained 
Dulbecco’s modified Eagle’s medium, 10% fetal bovine serum, 10% horse serum, 1% 
penicillin/streptomycin, and 0.5% chick embryo extract (Qu-Petersen et al., 2002). Myoblasts 
were cultured for less than 3 passages prior to each experiment. MDSCs were under passage 20. 
It is important to note that recent work has described that MDSCs can be cultured past the 
Hayflick limit for more than 200 doublings without any oncogenic or transformed properties, and 
still maintain their same regeneration ability as early passages (Hayflick 1960s, DEASY 2005). 
Antibodies specific for Pax7 (Developmental Studies Hybridoma Bank, Iowa City, IA, USA) 
and desmin (Sigma, St. Louis, MO, USA) were used as myogenic lineage-specific markers (Qu-
Petersen et al., 2002). All Pax7+ or desmin+ cells were counted in both cell populations. 
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4.4.2 Fusion Index 
The rate and degree of fusion was monitored in each cell population after incubation with H2O2 
and TNFα. Cells were plated at an initial plant density of 1,250 cells/cm2 in 48 well collagen 
coated plates, and cultured in high-serum, proliferation media. After 48 hrs, to induce 
differentiation the culture medium was replaced with low-serum medium containing 2% fetal 
bovine serum and 1% penicillin/streptomycin in Dulbecco’s modified Eagle’s medium. 
Immediately following incubation in the differentiaion medium, cell’s were exposed to H2O2 (10, 
25, 50, and 100µM; Sigma) and TNFα (1.0, 2.5, and 5.0 ng/mL; R&D Systems) to simulate 
oxidative and inflammatory stress. Media was replaced every two days with fresh differentiation 
media. After the initial stress, cell’s were not exposed to additional H2O2 or TNF-α unless 
otherwise noted. 
At day’s 0, 2, 3, and 4, plates were fixed in cold methanol, and fields were randomly 
selected and evaluated for the levels of fast myosin heavy chain-positive myofibers and 
counterstained with DAPI (Sigma). These images were used to measure the fusion index 
(Jankowski et al., 2002a) defined as the ratio of the total number of nuclei in myosin-heavy chain 
compared to the total number of nuclei of the entire cell population. Three wells were used at 
each time for each dose of either H2O2 and TNFα, and 6 fields were randomly selected in each 
well. This large number of images collected over an extended time period were analyzed using 
ImageFi, an open source, freely available program as described below in the image analysis 
methods section.     
4.4.3 Apoptosis 
To determine levels of cell death after exposure to oxidative stress, levels of apoptosis and 
necrosis were measured using flow cytometry. MDSCs and myoblasts were cultured for 24 hours 
under normal culture conditions, and then incubated in H2O2 (100, 250, and 500 μM) at 37C. 
After 15 hrs, the media was collected, the cells were washed in PBS, harvested in 0.01% trypsin-
EDTA (Gibco Laboratories), and quenched with proliferation media.  After centrifugation, the 
cell pellet and collected media was stained with annexin-V and propidium iodide according to 
manufacturer’s directions (BD Bioscience).  Levels of apoptosis and necrosis were measured 
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using flow cytometry (FACSAria; FACSDiva Software; BD Bioscience) with standard 
calibration and one color control for compensation of fluorochromes.  Total cell death was 
determined as the sum of necrotic and apoptotic cell death fractions normalized to exclude 
cellular debris.              
To monitor the levels of cell death over a continuous time period, a modified live cell 
microscopy technique was used to measure percentages of annexin-V positive cells. Cells were 
planted at an initial plant density of 2000 c/cm2 on collagen Type-I 24 well plates, and cultured 
for 24 hrs. Cells were loaded with Cell Tracker Red-CMTPX (Molecular Probes) according to 
manufacturer’s directions to aid in segmentation of the entire cell population. Cells were then 
placed in proliferation media containing 15 µg/mL of Annexin-V FITC (BD Bioscience) and 10 
µg/mL of propidium iodide. A microscope imaging system (Automated Cell, Inc) was used to 
acquire light and fluorescent time-lapsed images on a 30 min time interval (Bahnson et al., 2005; 
Deasy et al., 2002). At each time point, 9 images in each plate were collected resulting in over 
45,000 images being collected in each experiment with each experiment averaging over 1-3x105 
events being recorded. After an initial baseline measurement was collected, cells were incubated 
with increasing doses of H2O2 (10, 25, 50, 100, 250, and 500 µM; Sigma) and TNFα (1.0, 2.5, 
and 5.0 ng/mL; R&D Systems). Images were collected on a 30min interval over a 24-36hr time 
period. The percentages of annexin-positive cells in each population at each time period were 
measured using open source software. Further details are noted below.  
4.4.4 Oxidative Damage 
Protein oxidative damage was measured using the oxyblot oxidized protein detection kit 
(Chemicon) following the manufacturer’s protocol with important details and exceptions noted 
below. Myoblasts and MDSCs were seeded at 2000 c/cm2, exposed to 0, 10, 50, and 100 µM 
H2O2, after 24hrs, and harvested after an additional 24hrs. Protein concentrations were measured 
using the bovine serum albumin assay (Pierce). After 60µg of each sample were derivitized with 
DNPH, one dimensional electrophoresis was conducted on a 4-20% precast SDS/polyacrylamide 
gel (Bio-Rad). Proteins were transferred to nitrocellulose membranes, incubated in anti-DNPH 
and appropriate secondary antibody, and developed using a chemiluminescence detection system 
(Pierce). Following oxyblot analysis, the same membrane was stained for beta-actin as a control 
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to ensure similar levels of protein were loaded across each lane. Densitometry was performed on 
each lane using two-dimensional integration with local background substraction, and corrected 
relative to differences in the beta-actin band intensity.   
4.4.5 Antioxidant Capacity 
The ability of each cell population to avoid damage from oxidative stress was assessed by 
measuring the levels of free radicals, reduced glutathione, and levels of super oxide dismutase 
activity. Levels of reactive oxygen species were measured using 5-(and-6)-carboxy-2´,7´-
dichlorodihydrofluorescein diacetate (carboxy-H2DCFDA; Molecular Probes).  Carboxy-
H2DCFDA is a non-polar, nonfluorescent compound that freely crosses the cell membrane, and 
becomes charged and cell permanent over short time periods after hydrolysis with intracellular 
esterases. Oxidation following interactions with intracellular reactive oxygen species (ROS) 
results in conversion to 2',7'-dichlorofluorescein, a highly fluorescent compound. This change in 
fluorescence can be monitored using flow cytometry using appropriate single parameter controls. 
Briefly, cells were planted at 2500 c/cm2, and after 48 hours loaded with 5µM carboxy-
H2DCFDA for 30 min in proliferation media, washed, and exposed to 500 µM H2O2. At 15min 
time intervals, cells were harvested, and green fluorescence was immediately measured using 
flow cytometry (Hempel et al., 1999). 
Levels of reduced glutathione (GSH) were monitored using monochlorobimane (MCB; 
Molecular Probes), a nonfluorescent bimane that reacts with free GSH to form a highly 
fluorescent derivative. Cells were loaded with 4µM of MCB for 30 min in proliferation media, 
harvested, washed, and the fluorescence was measured using flow cytometry with single 
parameter controls. 
Total activity of superoxide dismutase (SOD) was measured using a colorimetric assay 
(Chemicon, APT290).   Myoblast and MDSC cell samples containing 2x106 cells were 
homogenized using a lysis buffer (10mM Tris(pH7.5), 150mN NaCl, 0.1mM EDTA, 0.5% 
Triton X-100) and centrifuged at 12000 x g for 10 minutes to collect cell lysate.  The lysate 
supernatant was then alloquated into a xanthine/xanthine oxidase solution which produces the 
superoxide ion.  A chromagen molecule binds to superoxide ion and can then absorb light at a 
490nm wavelength.  Increasing superoxide concentration and therefore chromagen absorbance 
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indicates decreasing SOD activity. SOD activity was quantified by generating a standardized 
absorbance curve of increasing concentrations of purified SOD in the same solution. 
4.4.6 GSH Depletion 
To asses the role of GSH in the MDSC regenerative capacity, MDSCs were depleted of cellular 
GSH using diethyl maleate (DEM). After 48 hours in standard culture conditions, cells were 
treated with 50 µM DEM for 2 hrs, washed twice in PBS, and then cultured in fresh proliferation 
media. In some in vitro experiments, multiple doses of DEM were tested. In these cases, cell 
population levels of GSH were depleted using an identical protocol as desribed above at various 
doses of DEM as described in the results. 
4.4.7 Cell Transplantation 
All animal surgical procedures were approved by The Institutional Animal Care and Use 
Committee, Children’s Hospital of Pittsburgh (Protocol 7/03). MDSCs and myoblasts were 
injected into mdx mice as initially described(Lee et al., 2000; Qu-Petersen et al., 2002). Briefly, 
2x105 viable cells were injected into the gastrocnemius muscle of 4-6 week old mdx mice 
(C57BL/10ScSn DMDmdx/J, The Jackson Laboratory) suspended 30µL of PBS. The mice used 
in the experiment were not immunosupressed, and the injected muscle was not injured before or 
after transplantation.  
Coronary ligation and cell transplantation into infarcted hearts were performed in 14 
week C57BL/10J; The Jackson Laboratory) as previously described (Oshima et al., 2005). 
Briefly, myocardial infarctions were induced by ligating the left anterior descending coronary 
artery 2mm from the left auricle. Immediately after ligation, 3x105 cells were injected into the 
anterior and lateral aspects of the wall bordering the infarct and into the center of the infarct in 
30µL of PBS (10µL per region). Mice were anesthetized using 1.0–1.5% isoflurane (Abbott 
Laboratories, North Chicago, IL, USA) in 100% O2 gas. In the control group, the identical 
procedure was used, except only PBS and no cells were injected. Echocardiography was 
performed at 6 weeks, and mice were sacrificed at 8 weeks for histological analysis. 
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Echocardiography was performed as previously described (Oshima et al., 2005). Briefly, 
analysis was completed by a blinded investigator using a Sequoia C256 system (Acuson, 
Mountain View, CA, USA) equipped with a 13-MHz linear-array transducer (15L8). Isoflurane 
gas was used to anesthetize the mice. It should be noted that although isoflurane gas may have a 
cardiodepressant effect, other groups have reported that echocardiographic assessment of cardiac 
function in mice anesthetized with isoflurane is comparable to that in unanesthetized mice 
(Takuma et al., 2001). Two dimensional images were obtained at the midpapillary muscle level. 
EDD was measured from at least six consecutive beats using the M-mode tracing. End systolic 
area (EAS) and end diastolic area (EDA) were determined from short axis images of the left 
ventricle.  The fractional area change (FAC) was calculated as FAC = [(EDA-ESA)÷EDA]   
4.4.8 Histological Analysis 
Skeletal muscle and hearts were harvested at the indicated time points, and frozen in 2-
methylbutane precooled in liquid nitrogen. Skeletal muscle was serially cross sectioned in 10 µm 
thick sections, and heart was serial cross sectioned from the apex to the base into sections 10 µM 
thick. Skeletal muscle sections were stained for dystrophin-positive myofibers as previously 
described(Qu-Petersen et al., 2002). Cardiac sections were stained for the skeletal muscle-
specific marker, myosin heavy chain to measure the engraftment area of transplanted cells. The 
area and size of infarction were identified and measured using the trichrome stain (Sigma). All 
fluorescence and bright field microscopy was performed using either a Nikon Eclipse E800 
microscope equipped with a Retiga EXi digital camres ( Q Imaging, Burnaby, BC, Canada) or a 
Leica DMIRB microscope with a Retiga 1300 digital camera (Q Imaging). All images were 
adquired with Northern Eclipse software (v6.0; Empix Imaging, Inc., Cheektowaga, NY, USE).     
4.4.9 Image Analysis 
Image analysis was conducted as noted above to measure levels of apoptosis over a continuous 
time period (ImageApop) and to measure the fusion index (ImageFI). All programs were written 
as open source, freely available code using the Insight Toolkit (ITK), an image segmentation and 
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registration C++ code library (Yoo et al., 2002). The programs and source code used for analysis 
have been permanently archived on the Insight Journal. 
4.4.10 Statistical Analysis 
Data is expressed as a mean ± standard deviation, except were noted. Direct comparisons 
between two cell populations were made using an unpaired, two-tailed Student’s t-test. Statistical 
significance was determined if P<0.05. All statistical tests were completed using R (R Core 
Development Team, 2006). Multiple group comparisons were made using two-way ANOVA, 
using the Student-Newman-Keuls pairwise comparison to determine significance levels.    
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5.0  CONCLUSION 
5.1 SPATIAL TEMPORAL REAL TIME CYTOMETRY 
An interesting new technology developed during this project was conducting live-cell 
microscopy analysis similar to flow cytometry. Future work will include expanding the capacity 
of this software so that cell populations will be segmented from the light microscopy images. 
This will open an additional fluorescent channel for analysis. Further, implementing cell tracking 
algorithms will allow the observation of the development of sub-populations of cells. Following 
cells across space and time will add two new dimensions that can not be observed with 
traditional flow cytometry technologies.  
5.2 ANTIOXIDANT CAPACITY: A NEW ADDITION TO STEMNESS? 
Recent literature developments highlight the use of a new term “stemness” to describe the 
properties that define a stem cell (Dernbach et al., 2004; Ramalho-Santos et al., 2002). These 
include upregulation of genes responsible for self-renewal and cell fate. Perhaps an important 
unconsidered stem cell property is its antioxidant capacity and corresponding resistance to stress. 
This seems logical. An area of injury is a hostile environment for a cell with low levels of 
oxygen following ischemia or vessel damage followed by high levels of oxidative stress and 
inflammation after reperfusion. The success of a cell population to regenerate tissue would be 
dependent on the ability to function in this noxious environment. Studies presented here add 
important evidence to a growing body of literature about eth importance of a resistance to stress 
in stem and progenitor cell populations (Dernbach et al., 2004; Evens et al., 2004; He et al., 
2004; Ramalho-Santos et al., 2002). 
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 5.3 ANTIOXIDANT CAPACITY: IMPLICATIONS IN MDSC DEVELOPMENT 
The important role of antioxidant capacity in the regenerative capacity of MDSCs also raises 
interesting questions regarding the developmental role of MDSCs. MDSCs are resistant to 
oxidative stress and myoblasts are impaired by oxidative stress, especially in their ability to fuse 
to form myotubes. As outlined in figure 4, MDSCs are believed to be a progenitor population of 
satellite cells and myoblasts because of the low levels of expression of myogenic markers. 
Further, it has been proposed that MDSC, satellite cell, and myoblast differentiation are related 
in a linear pattern. In this case, MDSCs differentiate into myofibers in a series of progressions to 
satellite cells and then myoblasts before fusing to form myofibers. This has two implications. 
First, there are two sources of oxidative stress: pre-transplantation and post-transplantation. If the 
majority of oxidative induced damage occurs prior to transplantation in a short time period, then 
this linear relationship between MDSCs and myoblasts is still plausible. Second, if oxidative 
stress plays a major role in the post-transplantation environment, then the relationship can 
become more complicated. If the levels of oxidative stress and ensuring inflammation persist 
over an extended period of time, then this suggests MDSC may have an alternative pathway to 
fuse and restore dystrophin-positive myofibers. Under a continuous level of oxidative stress and 
inflammation, if MDSCs differentiated into myoblasts, then these transplanted cells would be 
susceptible to oxidative stress as well, and the regenerative advantage of MDSCs as compared to 
myoblasts would be lost. This type of sink would be avoided if the levels of oxidative stress and 
inflammation occurred over a shorter time period in which MDSCs outlasted this stress and then 
differentiated into satellite cells. This would be similar to a time delayed response of MDSC to 
differentiation. These different scenarios are outlined in figure 21.  
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Figure 21: Possible Differentiation Pathways for MDSCs 
MDSCs are believed to differentiate towards myofibers in a linear progression through satellite 
cells and myoblasts.  This series, step-wise development is only possible if oxidative stress only 
plays a major role in the pre-transplantation environment during harvesting and handling of the 
cells or if MDSC differentiation is delayed until after oxidative stress and inflammation subsides 
in vivo. If MDSC differentiated into myoblasts in an environment of oxidative stress, then any 
regenerative advantage of the MDSCs as compared to myoblasts would be lost. Another 
possibility is that MDSCs differentiate into myofibers via an alternative pathway.       
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5.4 IMPLICATIONS FOR CELL THERAPIES 
An important possible contribution of this work is in the area of cell therapies in regenerative 
medicine. A challenge in cell transplantation is the large variation in regenerative capacity of 
different cell populations across different isolations. Currently, it is impossible to predict the 
regenerative capacity of a cell population until after transplantation. This is unsuitable if these 
therapies will successfully be used in the clinic. Rapid assays need to be designed that can test 
the regenerative capacity of a cell population in vitro or directly after isolation prior to 
transplantation. These studies suggest that a cell’s antioxidant phenotype may possess the 
potential to select populations of cells prior to transplantation to optimize tissue regeneration. 
Further, enhancing a cell population’s antioxidant capacity may increase its regenerative capacity 
after transplantation in vivo.  
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